<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Cell Infect Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Cell Infect Microbiol</journal-id><journal-id journal-id-type="pmc-domain-id">1860</journal-id><journal-id journal-id-type="pmc-domain">fcimb</journal-id><journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Cellular and Infection Microbiology</journal-title></journal-title-group><issn pub-type="epub">2235-2988</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC7358460</article-id><article-id pub-id-type="pmcid-ver">PMC7358460.1</article-id><article-id pub-id-type="pmcaid">7358460</article-id><article-id pub-id-type="pmcaiid">7358460</article-id><article-id pub-id-type="pmid">32733813</article-id><article-id pub-id-type="doi">10.3389/fcimb.2020.00309</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Cellular and Infection Microbiology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>C-Type Lectin Receptors in Host Defense Against Bacterial Pathogens</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Mnich</surname><given-names initials="ME">Malgorzata E.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/724250/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>van Dalen</surname><given-names initials="R">Rob</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/948019/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>van Sorge</surname><given-names initials="NM">Nina M.</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/104127/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Medical Microbiology, UMC Utrecht, Utrecht University</institution>, <addr-line>Utrecht</addr-line>, <country>Netherlands</country></aff><aff id="aff2"><sup>2</sup><institution>GSK</institution>, <addr-line>Siena</addr-line>, <country>Italy</country></aff><aff id="aff3"><sup>3</sup><institution>Interfaculty Institute of Microbiology and Infection Medicine, University of T&#252;bingen</institution>, <addr-line>T&#252;bingen</addr-line>, <country>Germany</country></aff><aff id="aff4"><sup>4</sup><institution>Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam</institution>, <addr-line>Amsterdam</addr-line>, <country>Netherlands</country></aff><aff id="aff5"><sup>5</sup><institution>Netherlands Reference Laboratory for Bacterial Meningitis, Amsterdam University Medical Center</institution>, <addr-line>Amsterdam</addr-line>, <country>Netherlands</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Amanda S. MacLeod, Duke University, United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: Cornelis Hendrik Hokke, Leiden University Medical Center, Netherlands; Wendy W. J. Unger, Sophia Children's Hospital, Netherlands</p></fn><corresp id="c001">*Correspondence: Nina M. van Sorge <email>n.m.vansorge@amsterdamumc.nl</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Microbes and Innate Immunity, a section of the journal Frontiers in Cellular and Infection Microbiology</p></fn></author-notes><pub-date pub-type="epub"><day>07</day><month>7</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>10</volume><issue-id pub-id-type="pmc-issue-id">351405</issue-id><elocation-id>309</elocation-id><history><date date-type="received"><day>13</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>22</day><month>5</month><year>2020</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2020</year></date></event><event event-type="pmc-live"><date><day>29</day><month>07</month><year>2020</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2020-07-31 12:56:24.723"><day>31</day><month>07</month><year>2020</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2020 Mnich, van Dalen and van Sorge.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Mnich, van Dalen and van Sorge</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fcimb-10-00309.pdf"/><abstract><p>Antigen-presenting cells (APCs) are present throughout the human body&#8212;in tissues, at barrier sites and in the circulation. They are critical for processing external signals to instruct both local and systemic responses toward immune tolerance or immune defense. APCs express an extensive repertoire of pattern-recognition receptors (PRRs) to detect and transduce these signals. C-type lectin receptors (CLRs) comprise a subfamily of PRRs dedicated to sensing glycans, including those expressed by commensal and pathogenic bacteria. This review summarizes recent findings on the recognition of and responses to bacteria by membrane-expressed CLRs on different APC subsets, which are discussed according to the primary site of infection. Many CLR-bacterial interactions promote bacterial clearance, whereas other interactions are exploited by bacteria to enhance their pathogenic potential. The discrimination between protective and virulence-enhancing interactions is essential to understand which interactions to target with new prophylactic or treatment strategies. CLRs are also densely concentrated at APC dendrites that sample the environment across intact barrier sites. This suggests an&#8211;as yet&#8211;underappreciated role for CLR-mediated recognition of microbiota-produced glycans in maintaining tolerance at barrier sites. In addition to providing a concise overview of identified CLR-bacteria interactions, we discuss the main challenges and potential solutions for the identification of new CLR-bacterial interactions, including those with commensal bacteria, and for in-depth structure-function studies on CLR-bacterial glycan interactions. Finally, we highlight the necessity for more relevant tissue-specific <italic toggle="yes">in vitro, in vivo</italic> and <italic toggle="yes">ex vivo</italic> models to develop therapeutic applications in this area.</p></abstract><kwd-group><kwd>bacteria</kwd><kwd>antigen-presenting cells</kwd><kwd>immunity</kwd><kwd>glycan</kwd><kwd>host-pathogen interaction</kwd><kwd>C-type lectin</kwd><kwd>pattern-recognition receptor</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">H2020 Marie Sklodowska-Curie Actions<named-content content-type="fundref-id">10.13039/100010665</named-content></funding-source><award-id rid="cn001">675106 </award-id></award-group><award-group><funding-source id="cn002">European Molecular Biology Organization<named-content content-type="fundref-id">10.13039/100004410</named-content></funding-source><award-id rid="cn002">EXC 2124</award-id></award-group></funding-group><counts><fig-count count="1"/><table-count count="1"/><equation-count count="0"/><ref-count count="171"/><page-count count="15"/><word-count count="13911"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>A large variety of bacterial species, collectively called the microbiome, lives in and on the human body. Most of these species have beneficial effects on human health, but opportunistic pathogens are also frequently present. In case of barrier defects or (temporary) immune system impairments, these microbes can enter tissues with the risk of causing local or, upon further dissemination, systemic infections. Fortunately, the human immune system is well-equipped with a wide range of innate pattern-recognition receptors (PRRs) that sense specific constituents or microbe-associated molecular patterns of bacteria. Among these PRRs, four different families are currently distinguished (Takeuchi and Akira, <xref rid="B134" ref-type="bibr">2010</xref>). Nucleotide-binding oligomerization domain-like receptors and retinoic acid-inducible gene-I-like receptors (RLRs) are the cytoplasmic sensors of a cell, whereas Toll-like receptors (TLRs) are expressed in endosomes and on the cell surface (Takeuchi and Akira, <xref rid="B134" ref-type="bibr">2010</xref>). The family of C-type lectin receptors (CLRs) include both transmembrane and soluble extracellular proteins (Brown et al., <xref rid="B15" ref-type="bibr">2018</xref>). On tissue-resident antigen-presenting cells (APCs), engagement of PRRs including CLRs triggers local cytokine production, which is important to attract other immune cells such as neutrophils from the circulation to the site of infection and clear invading microbes (Janela et al., <xref rid="B66" ref-type="bibr">2019</xref>; Sparber et al., <xref rid="B129" ref-type="bibr">2019</xref>). Moreover, CLR-induced APC activation is instrumental to instruct adaptive immunity, including T cell polarization through production of cytokines and expression of co-stimulatory molecules, antibody production as well as immunological memory formation (Brown et al., <xref rid="B15" ref-type="bibr">2018</xref>). The induction of these adaptive responses is indispensable for protection from reinfection and key for efficacy of vaccines. Therefore, a better understanding of CLR-bacterial glycan interactions could aid the development of therapeutic applications and vaccines.</p><p>CLRs are specialized in recognition of exposed sugar residues or sugar motifs present on self as well as non-self structures (Hoving et al., <xref rid="B59" ref-type="bibr">2014</xref>; Yan et al., <xref rid="B161" ref-type="bibr">2015</xref>). Recognition of specific glycans occurs through one or more carbohydrate recognition domains (CRDs) in a Ca<sup>2+</sup>-dependent manner. CLRs expressed on APCs can be divided based on their topology as type I and type II transmembrane proteins; type I receptors are characterized by the N-terminus pointing out of the cell and multiple CRDs, whereas type II receptors have their N-terminus directed toward the cytoplasm and an extracellular C-terminus that contains a single CRD (van Kooyk, <xref rid="B148" ref-type="bibr">2008</xref>). Receptors of both groups have a stalk region, a transmembrane region and an intracellular domain with or without a signaling motif. Within type I and type II receptors, CLRs can additionally be categorized based on conserved amino acid motifs in their CRDs that determine their glycan specificity and Ca<sup>2+</sup> coordination. CLRs with an EPN (Glu-Pro-Asn) amino acid motif in their CRD, such as DC-SIGN (CD209), langerin (CD207) and mannose receptor (MR, CD206), preferentially bind glycans with equatorial 3- and 4-hydroxyl groups such as mannose, fucose, and <italic toggle="yes">N</italic>-acetylglucosamine (GlcNAc) residues. On the other hand, CLRs with a QPD (Gln-Pro-Asp) motif preferentially bind glycans with axial 4-hydroxyl groups such as galactose and <italic toggle="yes">N</italic>-acetylgalactosamine (GalNAc) terminated glycans (Drickamer, <xref rid="B36" ref-type="bibr">1992</xref>). In humans, most CLRs possess the EPN motif, with the exception of Macrophage Galactose-type C-type lectin (MGL, CD301), which possesses the QPD motif (Drickamer and Taylor, <xref rid="B37" ref-type="bibr">2015</xref>). Despite the shared structural features of their CRDs, CLRs display considerable variation in overall structure, cellular expression profiles and signal transduction cascades. These differences have important consequences for the specific contributions of CLRs to antimicrobial immunity, since they strongly affect ligand specificity and the induced immune responses, which can either support host defense or allow immune escape. The role of CLRs in host defense against fungal, viral and mycobacterial infections has recently been reviewed by others (Liu et al., <xref rid="B76" ref-type="bibr">2017</xref>; Shiokawa et al., <xref rid="B125" ref-type="bibr">2017</xref>; Bermejo-Jambrina et al., <xref rid="B11" ref-type="bibr">2018</xref>). Instead, our review focuses on recent findings on the importance of CLRs in recognition of and responses to bacterial pathogens by APCs. In addition, we highlight tools and technologies used for the identification of new interactions, and discuss challenges in the choice of appropriate cell model systems and in the translation of <italic toggle="yes">in vitro</italic> to <italic toggle="yes">in vivo</italic> studies. We conclude our review with possible applications of the gathered knowledge for the development of new CLR targeting strategies in vaccines or CLR blocking to counter bacterial immune evasion (Lang et al., <xref rid="B71" ref-type="bibr">2011</xref>; Wamhoff et al., <xref rid="B155" ref-type="bibr">2019</xref>).</p></sec><sec id="s2"><title>Recognition of Bacterial Glycans by Tissue-Resident APCs</title><p>The bacterial cell wall is essential for bacterial survival; it defines bacterial cell shape, is critical to sequester ions for bacterial homeostasis and serves as a scaffold for proteins and glycopolymers, to name but a few important features (Silhavy et al., <xref rid="B127" ref-type="bibr">2010</xref>; Dorr et al., <xref rid="B35" ref-type="bibr">2019</xref>). As such, it is much more than a structure that provides resistance to physical stress or harmful environmental factors. In fact, the bacterial cell wall and all its associated structures provide an important interface for direct sensing and communication with the environment, including the host. Despite considerable differences in overall cell wall composition between Gram-positive and -negative bacteria, both classes of bacteria decorate their cell wall with glycans. The best studied examples are capsular polysaccharides, lipopolysaccharide (LPS) and peptidoglycan. Capsular polysaccharides and LPS are effective vaccine antigens when conjugated to protein carriers (glycoconjugate vaccines), whereas proteins in the peptidoglycan biosynthesis pathways are proven targets of antibiotics (Schneider and Sahl, <xref rid="B119" ref-type="bibr">2010</xref>; Rappuoli, <xref rid="B108" ref-type="bibr">2018</xref>). However, bacteria produce a much broader array of glycan structures, which are incorporated in glycolipids, proteins, flagella and glycopolymers (Tytgat and Lebeer, <xref rid="B141" ref-type="bibr">2014</xref>). All these structures are potential ligands for CLRs, and considerable insight into specific molecular interactions has been made the past decades (Prado Acosta and Lepenies, <xref rid="B104" ref-type="bibr">2019</xref>). Importantly, these studies have revealed that interactions between bacterial glycans and CLRs do not always support host defense. Instead, bacteria can exploit CLR interactions for immune evasion, resulting in subversion of host defense responses and increased morbidity. Consequently, detailed molecular and functional insight into bacterial glycan recognition by CLRs is critical to distinguish beneficial from detrimental interactions and inform the development of new treatment or prophylactic strategies.</p><p>The functional consequences of CLR engagement are determined by the encountered bacterial ligands but also on the location in the body where the interaction occurs. First, different tissues are populated with specific APC subtypes, which can be phenotypically distinguished from each other by presence of specific immunological markers (Bigley et al., <xref rid="B13" ref-type="bibr">2015</xref>; Alculumbre and Pattarini, <xref rid="B4" ref-type="bibr">2016</xref>; Gunawan et al., <xref rid="B52" ref-type="bibr">2016</xref>; Alcantara-Hernandez et al., <xref rid="B3" ref-type="bibr">2017</xref>; Collin and Bigley, <xref rid="B27" ref-type="bibr">2018</xref>). Second, the local microenvironment provides specific signals to induce APC tissue adaptation, resulting in different receptor expression profiles and migratory capacities of similar APC subtypes in different tissues (Lundberg et al., <xref rid="B80" ref-type="bibr">2013</xref>; Alcantara-Hernandez et al., <xref rid="B3" ref-type="bibr">2017</xref>; Collin and Bigley, <xref rid="B27" ref-type="bibr">2018</xref>). Here, we summarize and discuss specific interactions between CLRs and bacterial glycans (<xref ref-type="fig" rid="F1">Figure 1</xref>), categorized by tissue as relevant for site of bacterial entry.</p><fig id="F1" position="float" orientation="portrait"><label>Figure 1</label><caption><p>Graphical overview of the discussed C-type lectin receptors on various antigen-presenting cells. For every receptor, the known interacting bacterial species are indicated. Where known, the intracellular signaling motif or associated signaling adaptor molecule is stated. For simplicity, the oligomerization state of the CLRs is not incorporated in the Figure. FcR&#947;, Fc receptor gamma chain.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fcimb-10-00309-g0001.jpg"/></fig><sec><title>Skin</title><p>The skin represents the largest organ of the body and is colonized by a plethora of microorganisms (Byrd et al., <xref rid="B18" ref-type="bibr">2018</xref>). Immune cells of the skin constantly interact with microbes and their products, even deeper within the tissue, without causing infection or inflammation (Nakatsuji et al., <xref rid="B94" ref-type="bibr">2013</xref>). However, two common skin resident species, <italic toggle="yes">Staphylococcus aureus</italic> and <italic toggle="yes">Streptococcus pyogenes</italic>, are also frequent causes of skin infections (Cardona and Wilson, <xref rid="B21" ref-type="bibr">2015</xref>). Skin infections caused by these pathogens are diverse in their presentation and pose a risk for life-threatening systemic infections. Both these skin-tropic pathogens, but not other more abundant species, such as <italic toggle="yes">Staphylococcus epidermidis</italic> and <italic toggle="yes">Staphylococcus lugdunensis</italic>, interact with the CLR langerin (CD207) as confirmed by experiments using recombinant human langerin as well as ectopically-expressing langerin cell lines (van Dalen et al., <xref rid="B143" ref-type="bibr">2019a</xref>,<xref rid="B144" ref-type="bibr">b</xref>). Langerin is exclusively expressed on human Langerhans cells (LCs), which are a subclass of myeloid cells that are abundantly present in the skin epidermis. LCs form an important first line of defense against pathogens (Doebel et al., <xref rid="B34" ref-type="bibr">2017</xref>; Deckers et al., <xref rid="B32" ref-type="bibr">2018</xref>). Although most studies focus on skin LCs, their localization is not restricted to the skin; they are also present in mucosal tissues and other epithelial linings, for example foreskin, cervical mucosal tissue, tonsils, tongue and the upper respiratory tract (Patterson et al., <xref rid="B102" ref-type="bibr">2002</xref>; van der Vlist et al., <xref rid="B147" ref-type="bibr">2011</xref>).</p><p>Langerin is expressed as a trimer through oligomerization of the neck region, and its cytoplasmic tail contains a putative proline-rich signaling motif (Valladeau et al., <xref rid="B142" ref-type="bibr">2000</xref>; Stambach and Taylor, <xref rid="B130" ref-type="bibr">2003</xref>; Tateno et al., <xref rid="B137" ref-type="bibr">2010</xref>) (<xref rid="T1" ref-type="table">Table 1</xref>). Based on binding profiles of recombinant human langerin to individual microbes, glycan arrays, langerin has specificity for sulfated and mannosylated glycans as well as &#946;-glucans, which it binds in a Ca<sup>2+</sup>-dependent manner (de Jong et al., <xref rid="B31" ref-type="bibr">2010b</xref>; Feinberg et al., <xref rid="B41" ref-type="bibr">2010</xref>, <xref rid="B43" ref-type="bibr">2011</xref>; Hanske et al., <xref rid="B54" ref-type="bibr">2017</xref>). However, these particular glycans are unlikely to be involved in the interaction with <italic toggle="yes">S. pyogenes</italic> or <italic toggle="yes">S. aureus</italic>, as they are not produced by these bacterial species. Although the ligand of langerin on <italic toggle="yes">S. pyogenes</italic> has not been identified yet (van Dalen et al., <xref rid="B144" ref-type="bibr">2019b</xref>), human pharyngeal LCs have been observed to interact with <italic toggle="yes">S. pyogenes</italic> (Reed et al., <xref rid="B110" ref-type="bibr">1994</xref>). On <italic toggle="yes">S. aureus</italic>, the langerin ligand depends on the gene <italic toggle="yes">tarS</italic> as confirmed by binding studies comparing wild-type and isogenic mutant strains (van Dalen et al., <xref rid="B143" ref-type="bibr">2019a</xref>). <italic toggle="yes">TarS</italic> encodes a glycosyltransferase that attaches a conserved &#946;1,4-linked <italic toggle="yes">N</italic>-acetylglucosamine (&#946;1,4-GlcNAc) moiety on the surface glycopolymer wall teichoic acid (WTA) (Brown et al., <xref rid="B17" ref-type="bibr">2012</xref>), which is an important structural component of the Gram-positive bacterial cell wall (Brown et al., <xref rid="B16" ref-type="bibr">2013</xref>). Recognition of WTA &#946;1,4-GlcNAc increases cytokine production of Th1- and Th17-skewing cytokines by <italic toggle="yes">in vitro</italic>-generated LCs. Correspondingly, epicutaneous infection with <italic toggle="yes">S. aureus</italic> producing &#946;1,4-GlcNAc increases skin inflammation in human langerin transgenic mice (van Dalen et al., <xref rid="B143" ref-type="bibr">2019a</xref>). The use of langerin transgenic mice was required since the murine langerin homolog does not recognize <italic toggle="yes">S. aureus</italic> (van Dalen et al., <xref rid="B143" ref-type="bibr">2019a</xref>), which is of interest as <italic toggle="yes">S. aureus</italic> is not a mouse commensal. Species-specificity for this interaction may therefore reflect the extended co-evolution of <italic toggle="yes">S. aureus</italic> with the human host. Approximately 30% of the <italic toggle="yes">S. aureus</italic> strains are able to co-decorate WTA with the accessory modification &#945;1,4-GlcNAc, which requires the glycosyltransferase TarM (Xia et al., <xref rid="B159" ref-type="bibr">2010</xref>). Langerin does not interact with &#945;1,4-GlcNAc-modified WTA, but co-expression of &#945;1,4-GlcNAc and &#946;-GlcNAc decreased interaction with langerin, suggestion a possible strategy to evade detection by langerin (van Dalen et al., <xref rid="B143" ref-type="bibr">2019a</xref>) Recently, a third WTA glycosyltransferase, TarP, was identified in 5&#8211;10% of <italic toggle="yes">S. aureus</italic> strains (Gerlach et al., <xref rid="B49" ref-type="bibr">2018</xref>). TarP attaches &#946;1,3-GlcNAc to WTA (Gerlach et al., <xref rid="B49" ref-type="bibr">2018</xref>), but it is currently unknown whether or how this modification impacts interaction with langerin or responses by LCs. Several SNPs in the langerin CRD alter the ligand specificity of langerin (Feinberg et al., <xref rid="B42" ref-type="bibr">2013</xref>). These SNPs impair <italic toggle="yes">S. aureus</italic> recognition and uptake by langerin-expressing cells, thereby providing a potential increase in disease susceptibility (van Dalen et al., <xref rid="B144" ref-type="bibr">2019b</xref>). Intriguingly, interaction with <italic toggle="yes">S. pyogenes</italic> was much less affected by these SNPs. Although preliminary, these data seem to suggest that such genetic variation does not affect overall susceptibility to bacterial infections (van Dalen et al., <xref rid="B144" ref-type="bibr">2019b</xref>).</p><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Overview of human CLRs and their characteristics discussed in this review, and their characteristics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Common names</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Cellular expression pattern</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Signaling</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Glycan specificity</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Recognized bacteria</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Langerin (CD207, CLEC4K)</td><td valign="top" align="left" rowspan="1" colspan="1">LCs (Valladeau et al., <xref rid="B142" ref-type="bibr">2000</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown but contains intracellular proline-rich W<bold>P</bold>RE<bold>P</bold>P motif (Th&#233;paut et al., <xref rid="B139" ref-type="bibr">2009</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Mannose, fucose, GlcNAc (Feinberg et al., <xref rid="B43" ref-type="bibr">2011</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">S. aureus</italic> (van Dalen et al., <xref rid="B143" ref-type="bibr">2019a</xref>), <italic toggle="yes">S. pyogenes</italic> (van Dalen et al., <xref rid="B144" ref-type="bibr">2019b</xref>), <italic toggle="yes">Y. pestis</italic> (Yang et al., <xref rid="B164" ref-type="bibr">2015</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MGL (CD301, CLEC10A)</td><td valign="top" align="left" rowspan="1" colspan="1">Macrophages, DCs in skin and lymphoid organs (Raes et al., <xref rid="B107" ref-type="bibr">2005</xref>; van Vliet et al., <xref rid="B152" ref-type="bibr">2008</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown</td><td valign="top" align="left" rowspan="1" colspan="1">Galactose, &#945;- and &#946;-GalNAc (Suzuki et al., <xref rid="B133" ref-type="bibr">1996</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">S. aureus</italic> ST395 (Mnich et al., <xref rid="B93" ref-type="bibr">2019</xref>), <italic toggle="yes">C. jejuni</italic> (van Sorge et al., <xref rid="B150" ref-type="bibr">2009</xref>), <italic toggle="yes">N. gonorrhoeae</italic> (van Vliet et al., <xref rid="B153" ref-type="bibr">2009</xref>), <italic toggle="yes">E. coli</italic> (Maalej et al., <xref rid="B81" ref-type="bibr">2019</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">DC-SIGN (CD209, CLEC4L)</td><td valign="top" align="left" rowspan="1" colspan="1">DCs at mucosal surfaces, skin dermis and lymphoid organs, macrophages (Geijtenbeek et al., <xref rid="B46" ref-type="bibr">2000a</xref>,<xref rid="B47" ref-type="bibr">b</xref>; Soilleux et al., <xref rid="B128" ref-type="bibr">2002</xref>).</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown</td><td valign="top" align="left" rowspan="1" colspan="1">Mannose, &#945;1-3 and &#945;1-4 fucosylated glycans, GlcNAc (Suzuki et al., <xref rid="B133" ref-type="bibr">1996</xref>; van Vliet et al., <xref rid="B154" ref-type="bibr">2005</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">H. pylori</italic> (Bergman et al., <xref rid="B10" ref-type="bibr">2004</xref>), <italic toggle="yes">Y. pseudotuberculosis</italic> (Zhang et al., <xref rid="B170" ref-type="bibr">2006b</xref>), <italic toggle="yes">Y. pestis</italic> (Zhang et al., <xref rid="B169" ref-type="bibr">2008</xref>)<italic toggle="yes">, E. coli</italic> K12 (Zhang et al., <xref rid="B170" ref-type="bibr">2006b</xref>), <italic toggle="yes">N. meningitidis</italic> (Steeghs et al., <xref rid="B131" ref-type="bibr">2006</xref>), <italic toggle="yes">N. gonorrhoeae</italic> (Zhang et al., <xref rid="B168" ref-type="bibr">2006a</xref>), <italic toggle="yes">Salmonella enterica</italic> serovar Typhimurium (Zhang et al., <xref rid="B170" ref-type="bibr">2006b</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mincle (CLEC4E)</td><td valign="top" align="left" rowspan="1" colspan="1">Activated macrophages, some subpopulations of B cells (Matsumoto et al., <xref rid="B87" ref-type="bibr">1999</xref>; Kawata et al., <xref rid="B68" ref-type="bibr">2012</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">ITAM motif in associated FcR&#947; chain (Matsumoto et al., <xref rid="B87" ref-type="bibr">1999</xref>; Yamasaki et al., <xref rid="B160" ref-type="bibr">2008</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Broad range of self and non-self glycolipids (Lu et al., <xref rid="B78" ref-type="bibr">2018</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">K. pneumoniae</italic> (Sharma et al., <xref rid="B124" ref-type="bibr">2014</xref>), <italic toggle="yes">H. pylori</italic> (Devi et al., <xref rid="B33" ref-type="bibr">2015</xref>)<italic toggle="yes">, S. pyogenes</italic> (Imai et al., <xref rid="B64" ref-type="bibr">2018</xref>)<italic toggle="yes">, S. pneumoniae</italic> (Imai et al., <xref rid="B64" ref-type="bibr">2018</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Dectin-2 (CLEC6A)</td><td valign="top" align="left" rowspan="1" colspan="1">Macrophages, DCs, LCs, monocytes (Ariizumi et al., <xref rid="B5" ref-type="bibr">2000</xref>; Taylor et al., <xref rid="B138" ref-type="bibr">2005</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">ITAM motif in associated FcR&#947; chain (Sato et al., <xref rid="B116" ref-type="bibr">2006</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">&#945;-mannans (Fernandes et al., <xref rid="B44" ref-type="bibr">1999</xref>; Sato et al., <xref rid="B116" ref-type="bibr">2006</xref>; Saijo et al., <xref rid="B114" ref-type="bibr">2010</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Hafnia alvei</italic> (Wittmann et al., <xref rid="B158" ref-type="bibr">2016</xref>)<italic toggle="yes">, E. coli</italic> O9a (Wittmann et al., <xref rid="B158" ref-type="bibr">2016</xref>)</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">DC, dendritic cell; LC, Langerhans cell, ITAM, intracellular tyrosine-based activation motif; GlcNAc, N-acetylglucosamine; GalNAc, N-acetylgalactosamine</italic>.</p></table-wrap-foot></table-wrap><p>Another bacterium that can enter the body through the skin is the Gram-negative pathogen <italic toggle="yes">Yersinia pestis</italic>, the cause of plague. Infections with <italic toggle="yes">Y. pestis</italic> can occur after a bite from an infected flee, which delivers the bacterium directly into the tissue, past the protective layer of stratum corneum. Through interaction with langerin, <italic toggle="yes">Y. pestis</italic> can be phagocytosed by LCs (Yang et al., <xref rid="B164" ref-type="bibr">2015</xref>). In addition to langerin, <italic toggle="yes">Y. pestis</italic> also interacts with Dendritic-cell-specific intracellular adhesion molecule-3-grabbing non-integrin (DC-SIGN, CD209) (Zhang et al., <xref rid="B169" ref-type="bibr">2008</xref>), which is expressed on dendritic cells (DCs), but not LCs, in mucosal linings, skin dermis, and lymphoid organs and macrophages (Geijtenbeek et al., <xref rid="B46" ref-type="bibr">2000a</xref>,<xref rid="B47" ref-type="bibr">b</xref>; Soilleux et al., <xref rid="B128" ref-type="bibr">2002</xref>). DC-SIGN is expressed as a tetramer on the cell surface, with each monomer consisting of a single CRD, neck region and an intracellular domain (van Kooyk and Geijtenbeek, <xref rid="B149" ref-type="bibr">2003</xref>). Although triggering of DC-SIGN alone does not induce DC responses, activation of DC-SIGN modulates signaling cascades induced by other PRRs (Gringhuis et al., <xref rid="B50" ref-type="bibr">2009</xref>). DC-SIGN selectively recognizes oligosaccharides containing high mannose residues but also fucosylated structures in a Ca<sup>2+</sup>-dependent manner and tetramerization of the receptor favors the recognition of closely-spaced mannose residues on the target molecule (Mitchell et al., <xref rid="B91" ref-type="bibr">2001</xref>; Feinberg et al., <xref rid="B40" ref-type="bibr">2005</xref>; Yu et al., <xref rid="B166" ref-type="bibr">2009</xref>). For <italic toggle="yes">Y. pestis</italic>, the interaction with langerin and DC-SIGN occurs through the core oligosaccharide of LPS and strains that are genetically-engineered to cover the LPS core are defective in DC and LC invasion (Zhang et al., <xref rid="B169" ref-type="bibr">2008</xref>; Yang et al., <xref rid="B164" ref-type="bibr">2015</xref>). Lectin-dependent phagocytosis seems to favor dissemination of <italic toggle="yes">Y. pestis</italic> by facilitating migration of bacteria to the lymph nodes (Yang et al., <xref rid="B164" ref-type="bibr">2015</xref>, <xref rid="B163" ref-type="bibr">2019</xref>). However, additional infection experiments in knock-out mice are required to specifically link the observed phenotype to the langerin or DC-SIGN mouse homolog (Zhang et al., <xref rid="B169" ref-type="bibr">2008</xref>; Yang et al., <xref rid="B164" ref-type="bibr">2015</xref>, <xref rid="B163" ref-type="bibr">2019</xref>).</p><p>Skin macrophages and DCs, but not LCs, express the CLR Macrophage Galactose-type C-type lectin (MGL, CD301) (Raes et al., <xref rid="B107" ref-type="bibr">2005</xref>; van Vliet et al., <xref rid="B152" ref-type="bibr">2008</xref>). MGL is a homotrimeric receptor that interacts in a Ca<sup>2+</sup>-dependent manner with galactose and terminal GalNAc residues through the QPD motif in its CRD (Suzuki et al., <xref rid="B133" ref-type="bibr">1996</xref>; Marcelo et al., <xref rid="B85" ref-type="bibr">2014</xref>; Tanaka et al., <xref rid="B136" ref-type="bibr">2017</xref>). Recently, a specific lineage of <italic toggle="yes">S. aureus</italic> (ST395) was shown to interact with MGL, as based on binding experiments with recombinant human MGL (Mnich et al., <xref rid="B93" ref-type="bibr">2019</xref>). This interaction depends on the unique WTA structure of this <italic toggle="yes">S. aureus</italic> lineage, which is composed of a glycerol-phosphate (GroP) backbone (as opposed to ribitol-phosphate in all other described <italic toggle="yes">S. aureus</italic> lineages) decorated with &#945;-<italic toggle="yes">N</italic>-acetylgalactosamine (&#945;-GalNAc) (Winstel et al., <xref rid="B156" ref-type="bibr">2013</xref>, <xref rid="B157" ref-type="bibr">2014</xref>). WTA &#945;-GalNAc expression by wild-type <italic toggle="yes">S. aureus</italic> confers binding to human monocyte-derived dendritic cells (moDCs) and induces proinflammatory cytokine production compared to S. <italic toggle="yes">aureus</italic> strains genetically modified to lack &#945;-GalNAc expression (Mnich et al., <xref rid="B93" ref-type="bibr">2019</xref>). It remains to be determined whether the observed responses correspond to the responses of primary human macrophages or DCs isolated from skin. This knowledge is highly relevant to our understanding of the skin immune detection of these <italic toggle="yes">S. aureus</italic> strains.</p><p>In addition to interaction with langerin, <italic toggle="yes">S. pyogenes</italic> cell wall components also activate Macrophage inducible C-type lectin (Mincle). Mincle is modestly expressed under homeostatic conditions but significantly upregulated on resident and attracted myeloid cells and neutrophils upon infection or sterile inflammation in murine and human skin (Iborra et al., <xref rid="B63" ref-type="bibr">2016</xref>; Kostarnoy et al., <xref rid="B69" ref-type="bibr">2017</xref>). Increased expression results from increased transcriptional activity induced by inflammatory cytokines such as TNF-&#945;, IL-6, and IFN-&#947; (Matsumoto et al., <xref rid="B87" ref-type="bibr">1999</xref>). Enhanced surface expression and phagocytic capacity is also conferred by the formation of heteromeric complexes of Mincle with other CLRs such as macrophage C-type lectin (MCL) (Lobato-Pascual et al., <xref rid="B77" ref-type="bibr">2013</xref>). Despite the presence of an EPN motif in its CRD, which usually confers specificity for mannan, all Mincle ligands identified so far contain a lipid moiety in addition to the glycan, suggesting that glycolipids are the molecular signature required for Mincle recognition (Lu et al., <xref rid="B78" ref-type="bibr">2018</xref>). Mincle induces cellular activation through coupling with the Fc receptor common &#947; chain (FcR&#947;), which contains an intracellular ITAM signaling motif (Matsumoto et al., <xref rid="B87" ref-type="bibr">1999</xref>; Yamasaki et al., <xref rid="B160" ref-type="bibr">2008</xref>). Mincle interacts with glycolipid antigens from <italic toggle="yes">S. pyogenes</italic>, specifically the lipophilic components monoglucosyldiacylglycerol (MGDG) and diglycosyldiacylglycerol (DGDG) (Imai et al., <xref rid="B64" ref-type="bibr">2018</xref>), which constitute membrane anchors for lipoteichoic acid (LTA) in the bacterial cell envelope. Intriguingly, MGDG activates DCs via Mincle, resulting in antigen-induced IL-17 production from CD4+ T cells, whereas DGDG prevents MGDG-induced cellular activation through the same receptor (Imai et al., <xref rid="B64" ref-type="bibr">2018</xref>). Abrogation of Mincle-mediated <italic toggle="yes">S. pyogenes</italic> detection impairs production of pro-inflammatory cytokines, resulting in increased bacteremia and mortality in a mouse model of systemic infection (Imai et al., <xref rid="B64" ref-type="bibr">2018</xref>). Mincle-mediated protection depends on induction of interferon-&#947; by a specialized lineage of immature myeloid cells, which in turn requires TLR2-induced IL-6 production by these same cells (Matsumura et al., <xref rid="B88" ref-type="bibr">2019</xref>). As MGDG and DGDG are a product of the same biosynthetic pathway, controlled expression of these different lipid anchors may allow <italic toggle="yes">S. pyogenes</italic> to escape Mincle detection.</p><p>Overall, these examples highlight that APC subsets in the skin express distinct CLR repertoires that affect the molecular interaction and immunological responses upon bacterial infection. As DCs, macrophages and LCs are located at different anatomical depths, it is likely that the depth of infection is an important determinant for the outcome of infection. We believe this represents an important area of research to understand pathogenesis of bacterial skin infections (Quaresma, <xref rid="B106" ref-type="bibr">2019</xref>).</p></sec><sec><title>Genital Tract</title><p>DCs and LCs are both present at barrier sites of the genital tract. <italic toggle="yes">Neisseria gonorrhoeae</italic> is a Gram-negative pathogenic bacterium and the cause of the sexually-transmitted disease gonorrhea. It can express different lipooligosaccharide (LOS) variants that correlate with altered disease states, i.e. active disease is associated with <italic toggle="yes">N. gonorrhoeae</italic> variant C (Schneider et al., <xref rid="B118" ref-type="bibr">1991</xref>). <italic toggle="yes">N. gonorrhoeae</italic> variants A, B, and C only differ in their LOS glycosylation, expressing terminal GlcNAc, galactose and GalNAc, respectively (van Vliet et al., <xref rid="B153" ref-type="bibr">2009</xref>). Using these three well-defined <italic toggle="yes">N. gonorrhoeae</italic> variants, recombinant soluble CLR-constructs and human moDCs, it was discovered that <italic toggle="yes">N. gonorrhoeae</italic> variant C interacts with MGL, whereas <italic toggle="yes">N. gonorrhoeae</italic> variant A is detected by DC-SIGN. Engagement of MGL on moDCs by <italic toggle="yes">N. gonorrhoeae</italic> variant C shifts DC cytokine secretion and subsequent T helper differentiation toward Th2 in a co-culture system compared to <italic toggle="yes">N. gonorrhoeae</italic> variants A and B (Zhang et al., <xref rid="B168" ref-type="bibr">2006a</xref>; van Vliet et al., <xref rid="B153" ref-type="bibr">2009</xref>). The interaction with MGL is thought to benefit bacterial survival as a shift toward Th2 is considered to be a non-protective response against <italic toggle="yes">N. gonorrhoeae</italic> infection. So far, no interactions of LCs with bacteria relevant to genital tract infections or sexually-transmitted diseases have been studied.</p></sec><sec><title>Gastrointestinal Tract</title><p>The stomach is a hostile environment due to its very low pH. In fact, it was assumed for a long time that this was a sterile site of the body. However, <italic toggle="yes">Helicobacter pylori</italic>, a Gram-negative bacterium and cause of ulcers and stomach cancer, has evolved unique strategies to survive and colonize the gastric mucosa. Intriguingly, <italic toggle="yes">H. pylori</italic> expresses phase-variable LPS and LPS variants containing Lewis epitopes interact with DC-SIGN (Bergman et al., <xref rid="B10" ref-type="bibr">2004</xref>). Functional <italic toggle="yes">in vitro</italic> experiments using human moDCs and <italic toggle="yes">H. pylori</italic> strains with and without Lewis antigen epitopes on their LPS, demonstrated that engagement of DC-SIGN blocks Th1 development (Bergman et al., <xref rid="B10" ref-type="bibr">2004</xref>). This response is assumed to contribute to long-lasting colonization of <italic toggle="yes">H. pylori</italic> in a large proportion of the population. In addition to DC-SIGN, <italic toggle="yes">H. pylori</italic> also affects immune responses through Mincle as based on experiments with PMA-differentiated THP-1 cells, in which Mincle expression was strongly upregulated after exposure to <italic toggle="yes">H. pylori</italic>. Furthermore, Mincle expression decreases production of pro-inflammatory cytokines while concordantly increasing the production of anti-inflammatory IL-10 in response to <italic toggle="yes">H. pylori</italic> (Devi et al., <xref rid="B33" ref-type="bibr">2015</xref>). Computational modeling studies indicate that Mincle could interact with LPS of <italic toggle="yes">H. pylori</italic> containing Lewis-antigens (Devi et al., <xref rid="B33" ref-type="bibr">2015</xref>), but additional studies are required to confirm the interaction and relevance of <italic toggle="yes">H. pylori</italic>-Mincle interaction at a molecular level.</p><p>In contrast to the stomach, the intestines are colonized by a wealth of different bacterial species. Multiple interactions between pathogenic enteric bacteria and CLRs have been discovered. For example, DC-SIGN interacts with the core LPS, especially the GlcNAc residues, of many Gram-negative enteric pathogens, including <italic toggle="yes">Salmonella enterica</italic> serovar Typhimurium, <italic toggle="yes">E. coli</italic> K12 and <italic toggle="yes">Yersinia pseudotuberculosis</italic> (Zhang et al., <xref rid="B170" ref-type="bibr">2006b</xref>). The interaction between <italic toggle="yes">Y. pseudotuberculosis</italic> and DC-SIGN promotes systemic dissemination and further infection in mice (He et al., <xref rid="B56" ref-type="bibr">2019</xref>). For the other interactions the impact on infection is awaiting further studies. MGL is targeted by at least two gastrointestinal bacteria, <italic toggle="yes">Campylobacter jejuni</italic> and <italic toggle="yes">E. coli</italic> R1, through their LOS terminal GalNAc residues and, in case of <italic toggle="yes">C. jejuni</italic>, through expression of glycosylated proteins (van Sorge et al., <xref rid="B150" ref-type="bibr">2009</xref>; Maalej et al., <xref rid="B81" ref-type="bibr">2019</xref>). MGL targeting by <italic toggle="yes">C. jejuni</italic> suppresses IL-6 production by moDCs compared to isogenic <italic toggle="yes">C. jejuni</italic> mutant strains that lack <italic toggle="yes">N</italic>-glycan protein modifications (van Sorge et al., <xref rid="B150" ref-type="bibr">2009</xref>). Finally, the CLR Dendritic-cell-associated C-type lectin-2 (Dectin-2/CLEC6A) interacts with mannosylated O-antigen of LPS from the nosocomial bacterial pathogens <italic toggle="yes">Hafnia alvei</italic> and <italic toggle="yes">E. coli</italic> O9a (Wittmann et al., <xref rid="B158" ref-type="bibr">2016</xref>). Engagement of Dectin-2 by <italic toggle="yes">H. alvei</italic> mannosylated LPS enhances TLR4-induced cytokine responses of murine bone marrow-derived DCs (BM-DCs) as demonstrated using BM-DCs from Dectin-2 knockout mice (Wittmann et al., <xref rid="B158" ref-type="bibr">2016</xref>). Dectin-2-induced signaling also synergizes with TLR4 responses in human myeloid cells and is dependent on Syk (Wittmann et al., <xref rid="B158" ref-type="bibr">2016</xref>). These data suggest that Dectin-2 could have an important role in sensing bacteria that express mannosylated structures on their surface. The effect of Dectin-2 engagement for the outcome of infection requires further investigation.</p></sec><sec><title>Respiratory Tract</title><p>The respiratory tract is continuously exposed to airborne microorganisms, including potential pathogens. The distribution and density of APC subsets differs along the respiratory tract. For example, LCs are much more abundant in the upper respiratory tract but are scarce when descending toward the lung (van der Vlist et al., <xref rid="B147" ref-type="bibr">2011</xref>). On the other hand, subsets of DCs, which vary in expression of surface receptors and therefore likely in function, are observed within specific lung microenvironments (Patel and Metcalf, <xref rid="B101" ref-type="bibr">2018</xref>). More precise and comprehensive information on CLR expression along the respiratory tract would be helpful to further interpret results from studies demonstrating that CLRs can protect from bacterial pneumoniae. Specifically, Mincle was shown to have a critical role in protection from pneumonia caused by <italic toggle="yes">Klebsiella pneumoniae</italic> and <italic toggle="yes">Streptococcus pneumoniae</italic>. For <italic toggle="yes">K. pneumoniae</italic>, no bacterial ligand was identified but the increased susceptibility to pneumonia is associated with an increased bacterial burden and exaggerated hyperinflammation (Sharma et al., <xref rid="B124" ref-type="bibr">2014</xref>). The increased bacterial burden may be explained by defects in neutrophil-mediated clearance, as Mincle-deficient neutrophils show an impaired uptake of non-opsonized bacteria and impaired formation of neutrophil-extracellular traps (Sharma et al., <xref rid="B124" ref-type="bibr">2014</xref>, <xref rid="B123" ref-type="bibr">2017</xref>). A similar increase in pneumonia as well as mortality was observed in Mincle-knockout vs. wild-type mice challenged intrapulmonary with <italic toggle="yes">S. pneumoniae</italic> serotype 19F. The Mincle ligand of <italic toggle="yes">S. pneumoniae</italic> was identified as the LTA anchor moiety glucosyl-diacylglycerol (Glc-DAG), which is the same ligand as MGDG identified in <italic toggle="yes">S. pyogenes</italic> (Imai et al., <xref rid="B64" ref-type="bibr">2018</xref>). Engagement of Mincle was not sufficient to protect mice from invasive pneumococcal disease as caused by <italic toggle="yes">S. pneumoniae</italic> serotype 3, which is more aggressive compared to serotype 19F as this strain causes bacteremia in addition to pneumonia (Behler-Janbeck et al., <xref rid="B9" ref-type="bibr">2016</xref>). These results suggest that Mincle may contribute to local lung immunity against <italic toggle="yes">S. pneumoniae</italic> but is unable to contain bacteria once in the blood stream (Behler-Janbeck et al., <xref rid="B9" ref-type="bibr">2016</xref>). However, it is very difficult to draw firm conclusions on the role of Mincle in pneumococcal infection, since the strains were not quantified for expression of the Mincle ligand. In addition, the two strains are genetically quite diverse, which likely alters the molecular context in which the Mincle ligand is expressed. As discussed above, this could lead to co-engagement of additional cellular receptors, leading to a different outcome of Mincle activation. Therefore, additional studies are required to fully unravel the role of Mincle in anti-pneumococcal lung immunity.</p></sec><sec><title>Nasopharynx</title><p><italic toggle="yes">Neisseria meningitidis</italic> can colonize the nasopharynx of healthy individuals but is also a common cause of invasive disease, most notably sepsis and meningitis. Dependent on the molecular composition of <italic toggle="yes">N. meningitidis</italic> LPS, the strain can interact with DC-SIGN with important consequences for uptake and induction of adaptive immunity. Truncation of <italic toggle="yes">N. meningitidis</italic> LPS (&#916;<italic toggle="yes">lgtB</italic>; representative of immunotype L6) results in enhanced uptake by human moDCs through DC-SIGN and induction of anti-bacterial Th1 responses, as assessed by <italic toggle="yes">in vitro</italic> co-cultures with human primary cells (Steeghs et al., <xref rid="B131" ref-type="bibr">2006</xref>). Immunotype L6 is rarely found among clinical isolates, suggesting that interaction with DC-SIGN is unfavorable for <italic toggle="yes">N. meningitidis</italic> survival (Steeghs et al., <xref rid="B131" ref-type="bibr">2006</xref>). From an alternative perspective, immunotype L6 LPS may be used as a powerful vaccine adjuvant as it induces a favorable Th profile compared to unfavorable Th2 type responses with the currently approved human adjuvant alum.</p></sec><sec><title>CLR-Mediated Transcompartmental Sampling</title><p>The studies described so far all involve interactions between CLRs and pathogenic or nosocomial bacterial species within tissues. However, interactions with commensal members of the microbiome are also likely to occur (Li T. H. et al., <xref rid="B75" ref-type="bibr">2019</xref>). APCs at barrier sites such as the skin, gut or lung do not only respond to bacteria that have penetrated the epithelial barrier, but also have the capacity to actively sample the environment through extension of dendrites across the physical barriers (Rescigno et al., <xref rid="B112" ref-type="bibr">2001</xref>; Niess et al., <xref rid="B97" ref-type="bibr">2005</xref>; Jahnsen et al., <xref rid="B65" ref-type="bibr">2006</xref>; Sung et al., <xref rid="B132" ref-type="bibr">2006</xref>; Kubo et al., <xref rid="B70" ref-type="bibr">2009</xref>; Thornton et al., <xref rid="B140" ref-type="bibr">2012</xref>; Yoshida et al., <xref rid="B165" ref-type="bibr">2014</xref>). CLRs are concentrated at the tips of APC protrusions and are able to trigger localized antigen uptake (Baranov et al., <xref rid="B6" ref-type="bibr">2014</xref>), suggesting a critical role for CLRs in transcompartmental antigen sensing and uptake. The biological significance of this uptake process was demonstrated in a mouse model of staphylococcal scalded skin syndrome (SSSS), which depends on <italic toggle="yes">S. aureus</italic> exfoliating toxin (ET) (Ouchi et al., <xref rid="B100" ref-type="bibr">2011</xref>). Patch-immunization induces specific cellular and humoral immunity that protects mice from SSSS which depends on the presence of LCs (Ouchi et al., <xref rid="B100" ref-type="bibr">2011</xref>). Importantly, antigen-uptake through patch-immunization does not induce local inflammation or tissue damage (Ouchi et al., <xref rid="B100" ref-type="bibr">2011</xref>). As such, non-invasive application is being explored for development of vaccines against infectious agents (Zheng et al., <xref rid="B171" ref-type="bibr">2018</xref>). Investigations in this area may reveal a role for CLR-mediated APC transcompartmental uptake and activation in maintaining tissue homeostasis at barrier sites.</p></sec></sec><sec id="s3"><title>The Impact of Biological Variation on CLR-Bacterial Interactions</title><p>In many of the studies described above, new interactions were identified using a representative bacterial strain of the species of interest and a single growth condition. Biologically-relevant interactions may be missed using such a limited set of experimental conditions. First, the bacterial target may only be expressed in a specific environment or under specific growth condition as a result of regulation. We have recently observed this for the interaction between MGL and <italic toggle="yes">Staphylococcus lugdunensis</italic> (Mnich et al., <xref rid="B93" ref-type="bibr">2019</xref>). The gene encoding the bacterial glycosyltransferase TagN, responsible for the incorporation of GalNAc on WTA (Winstel et al., <xref rid="B156" ref-type="bibr">2013</xref>, <xref rid="B157" ref-type="bibr">2014</xref>), was identified in the <italic toggle="yes">S. lugdunensis</italic> genome, but no MGL binding to this bacterial strain was observed (Mnich et al., <xref rid="B93" ref-type="bibr">2019</xref>). In contrast, constitutive expression of <italic toggle="yes">S. lugdunensis tagN</italic> from a plasmid did confer MGL binding (Mnich et al., <xref rid="B93" ref-type="bibr">2019</xref>). These results seem to indicate lack of <italic toggle="yes">tagN</italic> expression in <italic toggle="yes">S. lugdunensis</italic> under our experimental growth conditions. Second, the target may only be present in a restricted subset or lineage from that specific species. Again, we can take the example of MGL interaction with GalNAc-decorated WTA, which is exclusive for the <italic toggle="yes">S. aureus</italic> ST395 lineage (Mnich et al., <xref rid="B93" ref-type="bibr">2019</xref>). Overall, the glycan expression profile or repertoire on the bacterial surface after <italic toggle="yes">in vitro</italic> growth may not be representative for the <italic toggle="yes">in vivo</italic> situation. Variation between strains from a single species can be estimated based on genetic studies, but, as illustrated with the example of <italic toggle="yes">S. lugdunensis</italic> above, the presence of a gene does not guarantee expression under the used experimental conditions. In addition to genetic sequences, information on conditions that induce the gene or glycan biosynthesis cluster of interested can be estimated by transcriptional data from a wide range of growth conditions (Mader et al., <xref rid="B82" ref-type="bibr">2016</xref>).</p><p>Even when a CLR-bacterial interaction is identified <italic toggle="yes">in vitro</italic>, translation to mouse models is often challenging as no murine homologs exist (e.g., DC-SIGN) or have vastly different glycan-binding profiles compared to the human CLR homolog (Hanske et al., <xref rid="B53" ref-type="bibr">2016</xref>; van Dalen et al., <xref rid="B143" ref-type="bibr">2019a</xref>). As an example of the latter, comparison of the glycan specificity using a bacterial glycan array for recombinantly-expressed murine and human langerin revealed a different binding pattern, in which murine langerin recognizes a broad set of bacterial glycans, but the binding pattern of human langerin is much more restricted (Hanske et al., <xref rid="B54" ref-type="bibr">2017</xref>). Therefore, results from mouse infection models where CLRs are implicated should be interpreted with care with regard to translation of the results for human infection.</p></sec><sec id="s4"><title>Multivalency and Epitope Density in CLR-Ligand Interactions</title><p>CLRs not only differ from many other receptors due to their specificity for glycans, but also in their preference for binding multivalent ligands and densely-expressed epitopes (Dam and Brewer, <xref rid="B29" ref-type="bibr">2010</xref>). Indeed, carbohydrate-protein interactions are usually of low affinity, which is overcome by multivalent display of the receptor and/or the ligand (Lepenies et al., <xref rid="B72" ref-type="bibr">2013</xref>). In addition, multivalency and epitope density contribute to discrimination between self and non-self and are not just based on the identity of the glycan, since similar glycan epitopes are often found in pathogens and the host (Medzhitov and Janeway, <xref rid="B90" ref-type="bibr">2002</xref>; Dam and Brewer, <xref rid="B29" ref-type="bibr">2010</xref>). Indeed, data from sugar competition assays for several receptors revealed that glycans carrying multiple carbohydrate epitopes have higher ability to bind to these receptors than monosaccharides (Hsu et al., <xref rid="B62" ref-type="bibr">2009</xref>). Studies that have systematically probed the effect of multivalency and configuration on binding capacity and cellular activation have been conducted for DC-SIGN and MGL (Eriksson et al., <xref rid="B39" ref-type="bibr">2014</xref>; Li R. E. et al., <xref rid="B74" ref-type="bibr">2019</xref>). Overall, higher glycan density increases lectin affinity and kinetics of binding, which is likely explained by one of the following concepts. The first is known as the &#8216;binding and sliding' mechanism, in which lectins constantly bind to and dissociate from the glycan epitope (Dam and Brewer, <xref rid="B28" ref-type="bibr">2008</xref>). By increasing the number of glycan epitopes along the surface, the lectin-epitope complex becomes longer and of higher affinity. This theory can be applied to soluble lectins such as galectins (Dam and Brewer, <xref rid="B28" ref-type="bibr">2008</xref>). In the second concept, lectins containing multiple CRDs align to allow simultaneous binding of multiple epitopes on a multivalent ligand in a face-to-face interaction (Dam and Brewer, <xref rid="B28" ref-type="bibr">2008</xref>). This concept is proposed for the binding mechanism of DC-SIGN, which forms a tetramer on the surface of DCs and thereby increases affinity for its ligands mannan and gp120 (Mitchell et al., <xref rid="B91" ref-type="bibr">2001</xref>; Bernhard et al., <xref rid="B12" ref-type="bibr">2004</xref>). Additionally, DC-SIGN becomes organized in nanoscale clusters within lipid rafts, which further supports ligand binding and internalization by DCs (Cambi et al., <xref rid="B19" ref-type="bibr">2004</xref>; Neumann et al., <xref rid="B96" ref-type="bibr">2008</xref>). Finally, it was suggested that for the interaction between highly mannosylated structures and DC-SIGN additional secondary binding sites on the CRD are present that further increase the binding affinity of multivalent epitopes (Mitchell et al., <xref rid="B91" ref-type="bibr">2001</xref>). Knowledge of binding and activation requirements have been exploited to target anti-cancer vaccines to DC-SIGN (Li R. E. et al., <xref rid="B74" ref-type="bibr">2019</xref>). Similar targeting strategies could be applied to other CLRs, which may provide the opportunity to target different APC subsets, such as LCs (Porkolab et al., <xref rid="B103" ref-type="bibr">2018</xref>; Neuhaus et al., <xref rid="B95" ref-type="bibr">2019</xref>; Wamhoff et al., <xref rid="B155" ref-type="bibr">2019</xref>).</p></sec><sec id="s5"><title>Interaction between CLRs and other PRR Family Members</title><p>Bacteria express a specific combination of PRR ligands. Complementary, PRRs have a specific distribution pattern among different APC subsets. Consequently, engagement of the same CLR can have a different immunological outcome as a result of different co-stimulation in that particular cell type. For example, engagement of MGL by <italic toggle="yes">S. aureus</italic> ST395 enhances IL-6 and IL-12 production by human moDCs (Mnich et al., <xref rid="B93" ref-type="bibr">2019</xref>), whereas engagement of MGL by <italic toggle="yes">C. jejuni</italic> glycosylated proteins dampens cytokine production by the same cell type (van Sorge et al., <xref rid="B150" ref-type="bibr">2009</xref>). Since it is known that MGL crosslinking does not induce cellular activation (van Vliet et al., <xref rid="B151" ref-type="bibr">2013</xref>; Heger et al., <xref rid="B57" ref-type="bibr">2018</xref>), these contrasting outcomes may result from differential TLR engagement for <italic toggle="yes">S. aureus</italic> (activating predominantly TLR2; Takeuchi et al., <xref rid="B135" ref-type="bibr">2000</xref>) and <italic toggle="yes">C. jejuni</italic> (activating predominantly TLR4; Rathinam et al., <xref rid="B109" ref-type="bibr">2009</xref>). A similar situation of differential co-stimulation may contribute to the different outcomes of langerin targeting by <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">Y. pestis</italic>. In this example, langerin-mediated <italic toggle="yes">S. aureus</italic> recognition induces production of Th1/Th17 cytokines, which is generally accepted to promote <italic toggle="yes">S. aureus</italic> clearance (van Dalen et al., <xref rid="B143" ref-type="bibr">2019a</xref>), whereas <italic toggle="yes">Y. pestis</italic> exploits langerin to gain entry into LCs to facilitate dissemination to the lymph nodes (Yang et al., <xref rid="B164" ref-type="bibr">2015</xref>). The exact molecular mechanism underlying these differential outcomes of langerin engagement by these two pathogens is currently not known. It is however intriguing to speculate that langerin targeting modulates intracellular signaling of co-triggered TLRs or possibly alters intracellular routing resulting in different antigen presentation. In the LC context, it is important to realize that these cells appear to express a restricted repertoire of TLRs compared to DCs, with consensus on absence of TLR4, TLR8, and TLR9 (Flacher et al., <xref rid="B45" ref-type="bibr">2006</xref>; van der Aar et al., <xref rid="B145" ref-type="bibr">2007</xref>). Consequently, LCs show no or little response to classical bacterial PAMPs such as LPS (Flacher et al., <xref rid="B45" ref-type="bibr">2006</xref>; van der Aar et al., <xref rid="B145" ref-type="bibr">2007</xref>).</p><p>For some CLRs, modulation of signaling pathways from other PRRs is well-characterized. For example, the intracellular signaling pathways of DC-SIGN and TLR4 converge in response to fucose-containing LPS from <italic toggle="yes">H. pylori</italic>, which skews immune responses from Th1 to Th2 (Bergman et al., <xref rid="B10" ref-type="bibr">2004</xref>; Gringhuis et al., <xref rid="B51" ref-type="bibr">2014</xref>). The molecular details for Th2 skewing have been identified and result from activation of the atypical NF-kB family member Bcl-3 by DC-SIGN, which represses TLR-induced proinflammatory cytokine expression (Gringhuis et al., <xref rid="B51" ref-type="bibr">2014</xref>). This opens up the possibility for therapeutic intervention; addition of anti-DC-SIGN blocking antibodies allow TLR activation to proceed normally, switching T cell responses toward Th1 (Gringhuis et al., <xref rid="B51" ref-type="bibr">2014</xref>), which is thought to enhance pathogen clearance. Another example is the CLR Dectin-2, which interacts with TLR4 signaling after mannosylated LPS (man-LPS) stimulation (Wittmann et al., <xref rid="B158" ref-type="bibr">2016</xref>). In contrast to BM-DCs from wild-type mice, BM-DCs from Dectin-2 and TLR4 knockout mice are unable to enhance IL-10 and TNF&#945; production after stimulation with Man-LPS, suggesting synergy between these two PRRs (Wittmann et al., <xref rid="B158" ref-type="bibr">2016</xref>). These examples illustrate the importance of studying CLR responses in the context of intact bacteria vs. purified components and also in the relevant APC subset to most closely resemble the complex biology of bacteria-APC interaction.</p></sec><sec id="s6"><title>Tools and Challenges in Screening for New Interactions</title><p>The described examples of CLR interaction with bacterial pathogens at different barrier sites highlight the importance of this PRR subfamily for pathogen detection and the instruction of appropriate downstream immune responses. As such, it is critical to identify new interactions to improve our understanding of immune tolerance, host defense and disease pathogenesis and apply this knowledge toward the development of new treatment and vaccines. Screening for new interactions between bacterial glycans and CLRs is challenging for multiple reasons. From a biological perspective, we are faced with an overwhelming diversity of glycans that are produced by bacterial species. For example, our gut microbiome contains an estimated 10<sup>13</sup> &#8722; 10<sup>14</sup> bacterial cells (Sender et al., <xref rid="B121" ref-type="bibr">2016a</xref>,<xref rid="B122" ref-type="bibr">b</xref>), which produce a plethora of carbohydrate-active enzymes (CAZymes; Cantarel et al., <xref rid="B20" ref-type="bibr">2009</xref>). Unfortunately, it is currently still challenging to predict glycan structures based on genome sequences. In addition, bacterial glycan expression is further regulated by specific environmental conditions in the gut. Interaction with neighboring bacteria may also affect the glycan composition, for example through secretion of glycan-hydrolyzing enzymes that modify (surface-associated) glycans from competitor bacteria. Screening for new interactions among this large diversity of glycans with different CLRs and elucidating their function requires a well-developed tool box. We will discuss developed tools below, as well as the advantages and disadvantages for each strategy.</p><p>CLRs can be recombinantly expressed as soluble extracellular domains, which facilitates screening of a diverse range of bacteria. Commercially available recombinant CLRs, both human and mouse, are often expressed as extracellular domains linked to a tag, such as IgG Fc (Hsu and Mahal, <xref rid="B60" ref-type="bibr">2009</xref>; Maglinao et al., <xref rid="B83" ref-type="bibr">2014</xref>; Mayer et al., <xref rid="B89" ref-type="bibr">2018</xref>). Due to the physical nature of IgG Fc, the soluble CLR-fusion proteins are expressed as dimers, which increases avidity of the CLR-glycan interaction compared to single soluble domains. However, the dimeric presentation does not reflect the natural arrangement of several CLRs, such as MGL, langerin and DC-SIGN, as trimers or tetramers on the cell surface (Feinberg et al., <xref rid="B40" ref-type="bibr">2005</xref>, <xref rid="B41" ref-type="bibr">2010</xref>; Jegouzo et al., <xref rid="B67" ref-type="bibr">2013</xref>). In addition, Fc-binding proteins are expressed by several bacterial species (Sidorin and Solov'eva, <xref rid="B126" ref-type="bibr">2011</xref>; Nordenfelt and Bjorck, <xref rid="B98" ref-type="bibr">2013</xref>), such as <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">S. pyogenes</italic>, and likely by other species, which further challenges screening for new interactions with these specific human pathogens due to high non-specific background binding. The use of non-Fc-based tags (such as Strep-tag II; Hanske et al., <xref rid="B53" ref-type="bibr">2016</xref>), orientation of the Fc-tagged constructs on arrays or on protein A/G-coated ELISA plates are possible solutions to prevent non-specific Fc-mediated binding (Chen et al., <xref rid="B23" ref-type="bibr">2008</xref>). Alternatively, lectins are spotted on an array, which can then be exposed to bacterial components or whole bacterial cells (Hsu et al., <xref rid="B61" ref-type="bibr">2006</xref>). This platform is able to produce a specific bacterial fingerprint and can assess dynamic changes to the bacterial glycan coat (Hsu et al., <xref rid="B61" ref-type="bibr">2006</xref>). The mentioned platform used well-defined plant lectins to probe the bacterial glycan profile. A similar platform consisting of mammalian CLRs would be a very valuable tool to identify new CLR-bacteria interactions. Finally, CLRs can be ectopically expressed on cell lines, potentially as GFP-reporter constructs (Imai et al., <xref rid="B64" ref-type="bibr">2018</xref>). This approach conserves the natural multimerization state of the receptor, but usually provides only a limited window in which specific interactions can be observed. Furthermore, GFP-reporter cell lines will only identify activating ligands, whereas CLR antagonists remain undetected. Additionally, since not all CLRs contain intrinsic signaling capacity, they need to be expressed as chimeric constructs for example with the CD3&#950; chain, which may alter their properties in unknown ways (Imai et al., <xref rid="B64" ref-type="bibr">2018</xref>).</p><p>With the aforementioned approaches, specific CLRs can be screened for interactions using intact bacteria. Alternatively, CLR constructs are used to screen glycan arrays (Rillahan and Paulson, <xref rid="B113" ref-type="bibr">2011</xref>; Geissner et al., <xref rid="B48" ref-type="bibr">2019</xref>), which display isolated bacterial glycans. This approach may benefit from the multivalent glycan display, which increases avidity of the interaction, allowing for identification of low affinity interactions. However, isolation of glycans from bacteria can be challenging due to the presence of labile groups or modifications that are lost during sample preparation (Lewis et al., <xref rid="B73" ref-type="bibr">2004</xref>; Edgar et al., <xref rid="B38" ref-type="bibr">2019</xref>). This has sparked the development of synthetic carbohydrate chemistry (Adamo, <xref rid="B2" ref-type="bibr">2017</xref>; van der Es et al., <xref rid="B146" ref-type="bibr">2017</xref>; Zhang and Ye, <xref rid="B167" ref-type="bibr">2018</xref>), which allows the generation of libraries consisting of stable and well-defined glycan structures. In addition, these defined structures enable structure-function studies and crystallography (Gerlach et al., <xref rid="B49" ref-type="bibr">2018</xref>). Crystallography with synthetic glycans is a useful approach once a CLR-glycan interaction is established but due to the vast number of glycosylated bacterial structures it does not allow for a comprehensive approach to screen for new glycan interactions across the entire bacterial kingdom. Complementary use of all mentioned tools is therefore essential to identify new interactions between bacteria and host CLR.</p></sec><sec id="s7"><title>Model Systems to Assess Functional Consequences of CLR Interaction</title><p>The above-mentioned studies have provided insight into the functional consequences of CLR-bacteria interactions. However, experimental work with APCs is not without technical and logistical challenges. First and foremost, the transcriptional profiles of APCs from the same subset can differ significantly depending on the tissue where they are isolated from, as cells receive specific signals from their surrounding microenvironment (Lundberg et al., <xref rid="B80" ref-type="bibr">2013</xref>). Consequently, APCs should ideally be isolated from the tissue of interest and be related to the infection route of the bacterium. However, isolation of primary APCs is not feasible for every tissue or for every laboratory due to limited availability or accessibility to human tissues. Even if the relevant tissues are obtained, it is challenging to isolate a suitable number of immature cells for experiments, due to limited cell numbers and (partial) induction of APC maturation by the isolation procedure (Botting et al., <xref rid="B14" ref-type="bibr">2017</xref>). Therefore, APCs differentiated from blood monocytes or CD34+ cord blood cells by a specific cocktail of cytokines, have become widely-used models to study APC- and CLR-induced responses. Using these differentiation strategies, APCs with an immature phenotype can be obtained and differentiated into mature APCs in a controlled manner. In addition to human primary cells, the use of cell lines that can be differentiated in distinct APCs subsets, such as the myeloid CD34+ MUTZ3 cell line (Masterson et al., <xref rid="B86" ref-type="bibr">2002</xref>; Santegoets et al., <xref rid="B115" ref-type="bibr">2006</xref>), have yielded more insight into CLR-mediated interaction and responses (de Jong et al., <xref rid="B30" ref-type="bibr">2010a</xref>; van Dalen et al., <xref rid="B143" ref-type="bibr">2019a</xref>). The advantages of this cell line-based approach are the absence of donor-to-donor variability, independence on donor-derived material and amenability of these cells to CRISPR/Cas9 genetic manipulation, which makes these cells suitable to address the role of specific molecules in immunological interactions. Another possibility to generate APCs is through induced pluripotent stem cells (iPSC) derived from fibroblasts, which offers an unlimited cell source from the same individuals and the possibility to generate patient-specific APCs with genetic defects (Choi et al., <xref rid="B25" ref-type="bibr">2009</xref>, <xref rid="B24" ref-type="bibr">2011</xref>; Yanagimachi et al., <xref rid="B162" ref-type="bibr">2013</xref>; Ackermann et al., <xref rid="B1" ref-type="bibr">2015</xref>). Although these approaches are understandably widely applied for ease of use and quantity of cells, transcriptomics studies have made clear that all <italic toggle="yes">in vitro</italic> differentiated cell and cell lines are distinct from primary cells (Lundberg et al., <xref rid="B79" ref-type="bibr">2001</xref>; Harman et al., <xref rid="B55" ref-type="bibr">2013</xref>). For example, MUTZ3-derived LCs express several TLRs that are not expressed by primary LCs (Lundberg et al., <xref rid="B80" ref-type="bibr">2013</xref>). Therefore, data obtained with differentiated primary cells, cell lines and iPSC should be interpreted with care, and experiments should be reproduced in more physiologically relevant primary cells, <italic toggle="yes">ex vivo</italic> tissue models or suitable <italic toggle="yes">in vivo</italic> models.</p><p>Fortunately, in recent years, several <italic toggle="yes">ex vivo</italic> and 3D tissue models have been developed. Human skin explants have been used to study the interaction between different cell populations and common skin pathogens, including <italic toggle="yes">S. aureus</italic> (Schaudinn et al., <xref rid="B117" ref-type="bibr">2017</xref>; Olaniyi et al., <xref rid="B99" ref-type="bibr">2018</xref>). This approach is currently the most relevant model to study the interaction of CLRs with bacteria in their natural environment, since the explanted tissue contains all relevant cell populations. Since not all laboratories have access to human skin, an alternative approach is the use of designed skin equivalents consisting of either epidermis alone or together with underlying dermis. Progress is made to repopulate these organotypic skin models with specific skin-resident immune cells (Pupovac et al., <xref rid="B105" ref-type="bibr">2018</xref>), for example CD34+ progenitor cells that differentiate into LCs when co-seeded with human keratinocytes (Regnier et al., <xref rid="B111" ref-type="bibr">1998</xref>). DCs can also be repopulated in the skin equivalent model by introducing human moDCs in between layers of keratinocytes and fibroblasts (Chau et al., <xref rid="B22" ref-type="bibr">2013</xref>). Not only for skin, but also for lung tissue, 3D tissue models have been generated to study molecular pathogenesis of bacterial infections, such as <italic toggle="yes">S. aureus</italic> toxin-mediated lung pathology relevant for pneumonia (Mairpady Shambat et al., <xref rid="B84" ref-type="bibr">2015</xref>). Also here it was possible to repopulate the model with functional human moDCs (Mizoguchi et al., <xref rid="B92" ref-type="bibr">2017</xref>).</p><p>The development of organoid technology has brought about a surge in the use of 3D models, also for studies in the area of infectious diseases (Schutgens and Clevers, <xref rid="B120" ref-type="bibr">2020</xref>). There are now a wide variety of tissues and organs that can be grown from human pluripotent stem cells (hPSCs) with a specific cocktail of growth factors including lung, gut, stomach and even brain organoids (Clevers, <xref rid="B26" ref-type="bibr">2016</xref>). Since organoids consist of all cellular components of the representative organ, they provide opportunities to study bacteria-host interactions in a more physiologically-relevant setting as compared to cell lines. For example, gastric organoids have been used to study host responses to <italic toggle="yes">H. pylori</italic> (Bartfeld et al., <xref rid="B8" ref-type="bibr">2015</xref>). Despite many advantages, organoids have limitations such as the absence of blood vessels and immune cells, which are crucial aspects of host defense against infections. The development of immune-competent organoids models (Bar-Ephraim et al., <xref rid="B7" ref-type="bibr">2020</xref>) will provide an opportunity to study interactions between CLR and bacteria in the fully differentiated context of different human tissues. Overall, all immunocompetent 3D tissue models can be useful tools to gain insight into bacterial-cell interactions and the influence of the specific environmental context on the functional outcomes of this interactions, i.e., influence of cell-cell communication.</p></sec><sec id="s8"><title>Conclusion and Future Outlook</title><p>From their first discovery, CLRs have been studied mainly for their role in anti-fungal and anti-viral immunity, with research on CLR-bacterial interactions lagging behind. Our overview of bacterial-CLR interactions clearly highlights the importance of specific CLRs in anti-bacterial immunity, but also provides examples of pathogens such as <italic toggle="yes">Y. pestis</italic> that exploit CLR interaction to enhance virulence or survival. Studies have generally focused on the role of CLRs in the detection of bacterial pathogens. However, APCs also actively sample the environment across intact tissue barriers, suggesting an important role in immune homeostasis that has yet to be elucidated. A major challenge in the identification of new interactions of CLRs with bacterial species in the microbiome is the vast diversity of bacterial glycan structures, in combination with technical challenges that have to be overcome to close this knowledge gap. In this review, we have discussed advantages and disadvantages of currently available approaches. Applications of CLR-bacterial interactions include the development of targeting agents for vaccine delivery to specific CLRs on APC subsets, that can help boost an effective adaptive immune and memory response. In this regard, the infectious diseases field should take advantage of the progress in the area of cancer vaccinology, where studies have shown the benefit of <italic toggle="yes">in vivo</italic> targeting of cancer antigens to APCs to enhance anti-tumor immunity (Hossain and Wall, <xref rid="B58" ref-type="bibr">2019</xref>). Overall, the knowledge gained from studies on bacterial-CLR interactions could therefore not only shed light on the role in immune defense or pathogenicity but also be highly relevant to the translation of vaccine applications.</p></sec><sec id="s9"><title>Author Contributions</title><p>MM, RD, and NS wrote, revised, and approved the manuscript. MM prepared the figure and table. All authors contributed to the article and approved the submitted version.</p></sec><sec id="s10"><title>Conflict of Interest</title><p>MM is a Ph.D. fellow who is enrolled in the Infection and Immunity Ph.D. program, part of the Graduate School of Life Sciences at Utrecht University, and participates in a postgraduate studentship program at GSK. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>Figure was created with <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.Biorender.com">Biorender.com</ext-link>.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by the European Union's Horizon 2020 research H2020-MSCA-ITN (No. 675106 coordinated by Dr. Fabio Bagnoli, GSK, Siena, Italy). RD was supported by the European Molecular Biology Organization and acknowledges infrastructural support by the Cluster of Excellence Controlling Microbes to Fight Infections (EXC 2124) of the German Research Foundation.</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ackermann</surname><given-names>M.</given-names></name><name name-style="western"><surname>Liebhaber</surname><given-names>S.</given-names></name><name name-style="western"><surname>Klusmann</surname><given-names>J. H.</given-names></name><name name-style="western"><surname>Lachmann</surname><given-names>N.</given-names></name></person-group> (<year>2015</year>). <article-title>Lost in translation: pluripotent stem cell-derived hematopoiesis</article-title>. <source>EMBO Mol. Med.</source><volume>7</volume>, <fpage>1388</fpage>&#8211;<lpage>1402</lpage>. <pub-id pub-id-type="doi">10.15252/emmm.201505301</pub-id><pub-id pub-id-type="pmid">26174486</pub-id><pub-id pub-id-type="pmcid">PMC4644373</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adamo</surname><given-names>R.</given-names></name></person-group> (<year>2017</year>). <article-title>Advancing homogeneous antimicrobial glycoconjugate vaccines</article-title>. <source>Acc. Chem. Res.</source><volume>50</volume>, <fpage>1270</fpage>&#8211;<lpage>1279</lpage>. <pub-id pub-id-type="doi">10.1021/acs.accounts.7b00106</pub-id><pub-id pub-id-type="pmid">28463499</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alcantara-Hernandez</surname><given-names>M.</given-names></name><name name-style="western"><surname>Leylek</surname><given-names>R.</given-names></name><name name-style="western"><surname>Wagar</surname><given-names>L. E.</given-names></name><name name-style="western"><surname>Engleman</surname><given-names>E. G.</given-names></name><name name-style="western"><surname>Keler</surname><given-names>T.</given-names></name><name name-style="western"><surname>Marinkovich</surname><given-names>M. P.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>High-dimensional phenotypic mapping of human dendritic cells reveals interindividual variation and tissue specialization</article-title>. <source>Immunity</source><volume>47</volume>, <fpage>1037</fpage>&#8211;<lpage>1050.e1036</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2017.11.001</pub-id><pub-id pub-id-type="pmid">29221729</pub-id><pub-id pub-id-type="pmcid">PMC5738280</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alculumbre</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pattarini</surname><given-names>L.</given-names></name></person-group> (<year>2016</year>). <article-title>Purification of human dendritic cell subsets from peripheral blood</article-title>. <source>Methods Mol. Biol.</source><volume>1423</volume>, <fpage>153</fpage>&#8211;<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-3606-9_11</pub-id><pub-id pub-id-type="pmid">27142015</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ariizumi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>G. L.</given-names></name><name name-style="western"><surname>Shikano</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ritter</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zukas</surname><given-names>P.</given-names><suffix>3rd</suffix></name><name name-style="western"><surname>Edelbaum</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2000</year>). <article-title>Cloning of a second dendritic cell-associated C-type lectin (dectin-2) and its alternatively spliced isoforms</article-title>. <source>J. Biol. Chem.</source><volume>275</volume>, <fpage>11957</fpage>&#8211;<lpage>11963</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.275.16.11957</pub-id><pub-id pub-id-type="pmid">10766825</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baranov</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ter Beest</surname><given-names>M.</given-names></name><name name-style="western"><surname>Reinieren-Beeren</surname><given-names>I.</given-names></name><name name-style="western"><surname>Cambi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Figdor</surname><given-names>C. G.</given-names></name><name name-style="western"><surname>van den Bogaart</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>Podosomes of dendritic cells facilitate antigen sampling</article-title>. <source>J. Cell Sci.</source><volume>127</volume>, <fpage>1052</fpage>&#8211;<lpage>1064</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.141226</pub-id><pub-id pub-id-type="pmid">24424029</pub-id><pub-id pub-id-type="pmcid">PMC4054684</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bar-Ephraim</surname><given-names>Y. E.</given-names></name><name name-style="western"><surname>Kretzschmar</surname><given-names>K.</given-names></name><name name-style="western"><surname>Clevers</surname><given-names>H.</given-names></name></person-group> (<year>2020</year>). <article-title>Organoids in immunological research</article-title>. <source>Nat. Rev. Immunol.</source><volume>20</volume>, <fpage>279</fpage>&#8211;<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1038/s41577-019-0248-y</pub-id><pub-id pub-id-type="pmid">31853049</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bartfeld</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bayram</surname><given-names>T.</given-names></name><name name-style="western"><surname>van de Wetering</surname><given-names>M.</given-names></name><name name-style="western"><surname>Huch</surname><given-names>M.</given-names></name><name name-style="western"><surname>Begthel</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kujala</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title><italic toggle="yes">In vitro</italic> expansion of human gastric epithelial stem cells and their responses to bacterial infection</article-title>. <source>Gastroenterology</source><volume>148</volume>, <fpage>126</fpage>&#8211;<lpage>136</lpage>. e126. <pub-id pub-id-type="doi">10.1053/j.gastro.2014.09.042</pub-id><pub-id pub-id-type="pmid">25307862</pub-id><pub-id pub-id-type="pmcid">PMC4274199</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Behler-Janbeck</surname><given-names>F.</given-names></name><name name-style="western"><surname>Takano</surname><given-names>T.</given-names></name><name name-style="western"><surname>Maus</surname><given-names>R.</given-names></name><name name-style="western"><surname>Stolper</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jonigk</surname><given-names>D.</given-names></name><name name-style="western"><surname>Tort Tarres</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>C-type lectin mincle recognizes glucosyl-diacylglycerol of <italic toggle="yes">streptococcus pneumoniae</italic> and plays a protective role in pneumococcal pneumonia</article-title>. <source>PLoS Pathog</source><volume>12</volume>:<fpage>e1006038</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1006038</pub-id><pub-id pub-id-type="pmid">27923071</pub-id><pub-id pub-id-type="pmcid">PMC5140071</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bergman</surname><given-names>M. P.</given-names></name><name name-style="western"><surname>Engering</surname><given-names>A.</given-names></name><name name-style="western"><surname>Smits</surname><given-names>H. H.</given-names></name><name name-style="western"><surname>van Vliet</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>van Bodegraven</surname><given-names>A. A.</given-names></name><name name-style="western"><surname>Wirth</surname><given-names>H. P.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title><italic toggle="yes">Helicobacter pylori</italic> modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN</article-title>. <source>J. Exp. Med.</source><volume>200</volume>, <fpage>979</fpage>&#8211;<lpage>990</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20041061</pub-id><pub-id pub-id-type="pmid">15492123</pub-id><pub-id pub-id-type="pmcid">PMC2211851</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bermejo-Jambrina</surname><given-names>M.</given-names></name><name name-style="western"><surname>Eder</surname><given-names>J.</given-names></name><name name-style="western"><surname>Helgers</surname><given-names>L. C.</given-names></name><name name-style="western"><surname>Hertoghs</surname><given-names>N.</given-names></name><name name-style="western"><surname>Nijmeijer</surname><given-names>B. M.</given-names></name><name name-style="western"><surname>Stunnenberg</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>C-Type lectin receptors in antiviral immunity and viral escape</article-title>. <source>Front. Immunol.</source><volume>9</volume>:<fpage>590</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.00590</pub-id><pub-id pub-id-type="pmid">29632536</pub-id><pub-id pub-id-type="pmcid">PMC5879224</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernhard</surname><given-names>O. K.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wilkinson</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sheil</surname><given-names>M. M.</given-names></name><name name-style="western"><surname>Cunningham</surname><given-names>A. L.</given-names></name></person-group> (<year>2004</year>). <article-title>Proteomic analysis of DC-SIGN on dendritic cells detects tetramers required for ligand binding but no association with CD4</article-title>. <source>J. Biol. Chem.</source><volume>279</volume>, <fpage>51828</fpage>&#8211;<lpage>51835</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M402741200</pub-id><pub-id pub-id-type="pmid">15385553</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bigley</surname><given-names>V.</given-names></name><name name-style="western"><surname>McGovern</surname><given-names>N.</given-names></name><name name-style="western"><surname>Milne</surname><given-names>P.</given-names></name><name name-style="western"><surname>Dickinson</surname><given-names>R.</given-names></name><name name-style="western"><surname>Pagan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cookson</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells</article-title>. <source>J. Leukoc. Biol.</source><volume>97</volume>, <fpage>627</fpage>&#8211;<lpage>634</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.1HI0714-351R</pub-id><pub-id pub-id-type="pmid">25516751</pub-id><pub-id pub-id-type="pmcid">PMC4370053</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Botting</surname><given-names>R. A.</given-names></name><name name-style="western"><surname>Bertram</surname><given-names>K. M.</given-names></name><name name-style="western"><surname>Baharlou</surname><given-names>H.</given-names></name><name name-style="western"><surname>Sandgren</surname><given-names>K. J.</given-names></name><name name-style="western"><surname>Fletcher</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rhodes</surname><given-names>J. W.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Phenotypic and functional consequences of different isolation protocols on skin mononuclear phagocytes</article-title>. <source>J. Leukoc. Biol.</source><volume>101</volume>, <fpage>1393</fpage>&#8211;<lpage>1403</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.4A1116-496R</pub-id><pub-id pub-id-type="pmid">28270408</pub-id><pub-id pub-id-type="pmcid">PMC5433859</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>G. D.</given-names></name><name name-style="western"><surname>Willment</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Whitehead</surname><given-names>L.</given-names></name></person-group> (<year>2018</year>). <article-title>C-type lectins in immunity and homeostasis</article-title>. <source>Nat. Rev. Immunol.</source><volume>18</volume>, <fpage>374</fpage>&#8211;<lpage>389</lpage>. <pub-id pub-id-type="doi">10.1038/s41577-018-0004-8</pub-id><pub-id pub-id-type="pmid">29581532</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>S.</given-names></name><name name-style="western"><surname>Santa Maria</surname><given-names>J. P.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Walker</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Wall teichoic acids of Gram-positive bacteria</article-title>. <source>Annu. Rev. Microbiol.</source><volume>67</volume>, <fpage>313</fpage>&#8211;<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-micro-092412-155620</pub-id><pub-id pub-id-type="pmid">24024634</pub-id><pub-id pub-id-type="pmcid">PMC3883102</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>S.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>G.</given-names></name><name name-style="western"><surname>Luhachack</surname><given-names>L. G.</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>J.</given-names></name><name name-style="western"><surname>Meredith</surname><given-names>T. C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Methicillin resistance in <italic toggle="yes">Staphylococcus aureus</italic> requires glycosylated wall teichoic acids</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>109</volume>, <fpage>18909</fpage>&#8211;<lpage>18914</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1209126109</pub-id><pub-id pub-id-type="pmid">23027967</pub-id><pub-id pub-id-type="pmcid">PMC3503181</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Byrd</surname><given-names>A. L.</given-names></name><name name-style="western"><surname>Belkaid</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Segre</surname><given-names>J. A.</given-names></name></person-group> (<year>2018</year>). <article-title>The human skin microbiome</article-title>. <source>Nat. Rev. Microbiol.</source><volume>16</volume>, <fpage>143</fpage>&#8211;<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro.2017.157</pub-id><pub-id pub-id-type="pmid">29332945</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cambi</surname><given-names>A.</given-names></name><name name-style="western"><surname>de Lange</surname><given-names>F.</given-names></name><name name-style="western"><surname>van Maarseveen</surname><given-names>N. M.</given-names></name><name name-style="western"><surname>Nijhuis</surname><given-names>M.</given-names></name><name name-style="western"><surname>Joosten</surname><given-names>B.</given-names></name><name name-style="western"><surname>van Dijk</surname><given-names>E. M.</given-names></name><etal/></person-group>. (<year>2004</year>). <article-title>Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells</article-title>. <source>J. Cell Biol.</source><volume>164</volume>, <fpage>145</fpage>&#8211;<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200306112</pub-id><pub-id pub-id-type="pmid">14709546</pub-id><pub-id pub-id-type="pmcid">PMC2171967</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cantarel</surname><given-names>B. L.</given-names></name><name name-style="western"><surname>Coutinho</surname><given-names>P. M.</given-names></name><name name-style="western"><surname>Rancurel</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bernard</surname><given-names>T.</given-names></name><name name-style="western"><surname>Lombard</surname><given-names>V.</given-names></name><name name-style="western"><surname>Henrissat</surname><given-names>B.</given-names></name></person-group> (<year>2009</year>). <article-title>The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics</article-title>. <source>Nucleic Acids Res.</source><volume>37</volume>, <fpage>D233</fpage>&#8211;<lpage>D238</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkn663</pub-id><pub-id pub-id-type="pmid">18838391</pub-id><pub-id pub-id-type="pmcid">PMC2686590</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cardona</surname><given-names>A. F.</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>S. E.</given-names></name></person-group> (<year>2015</year>). <article-title>Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment</article-title>. <source>Clin. Infect. Dis.</source><volume>61</volume>(<issue>Suppl. 2</issue>), <fpage>S69</fpage>&#8211;<lpage>S78</lpage>. <pub-id pub-id-type="doi">10.1093/cid/civ528</pub-id><pub-id pub-id-type="pmid">26316560</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chau</surname><given-names>D. Y.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>C.</given-names></name><name name-style="western"><surname>MacNeil</surname><given-names>S.</given-names></name><name name-style="western"><surname>Haycock</surname><given-names>J. W.</given-names></name><name name-style="western"><surname>Ghaemmaghami</surname><given-names>A. M.</given-names></name></person-group> (<year>2013</year>). <article-title>The development of a 3D immunocompetent model of human skin</article-title>. <source>Biofabrication</source><volume>5</volume>:<fpage>035011</fpage>. <pub-id pub-id-type="doi">10.1088/1758-5082/5/3/035011</pub-id><pub-id pub-id-type="pmid">23880658</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>M. L.</given-names></name><name name-style="western"><surname>Adak</surname><given-names>A. K.</given-names></name><name name-style="western"><surname>Yeh</surname><given-names>N. C.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>W. B.</given-names></name><name name-style="western"><surname>Chuang</surname><given-names>Y. J.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>C. H.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Fabrication of an oriented Fc-fused lectin microarray through boronate formation</article-title>. <source>Angew. Chem. Int. Ed. Engl.</source><volume>47</volume>, <fpage>8627</fpage>&#8211;<lpage>8630</lpage>. <pub-id pub-id-type="doi">10.1002/anie.200803377</pub-id><pub-id pub-id-type="pmid">18850623</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>K. D.</given-names></name><name name-style="western"><surname>Vodyanik</surname><given-names>M.</given-names></name><name name-style="western"><surname>Slukvin</surname><given-names>I. I.</given-names></name></person-group> (<year>2011</year>). <article-title>Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells</article-title>. <source>Nat. Protoc.</source><volume>6</volume>, <fpage>296</fpage>&#8211;<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2010.184</pub-id><pub-id pub-id-type="pmid">21372811</pub-id><pub-id pub-id-type="pmcid">PMC3066067</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>K. D.</given-names></name><name name-style="western"><surname>Vodyanik</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Slukvin</surname><given-names>I. I.</given-names></name></person-group> (<year>2009</year>). <article-title>Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors</article-title>. <source>J. Clin. Invest.</source><volume>119</volume>, <fpage>2818</fpage>&#8211;<lpage>2829</lpage>. <pub-id pub-id-type="doi">10.1172/JCI38591</pub-id><pub-id pub-id-type="pmid">19726877</pub-id><pub-id pub-id-type="pmcid">PMC2735935</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clevers</surname><given-names>H.</given-names></name></person-group> (<year>2016</year>). <article-title>Modeling development and disease with organoids</article-title>. <source>Cell</source><volume>165</volume>, <fpage>1586</fpage>&#8211;<lpage>1597</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.05.082</pub-id><pub-id pub-id-type="pmid">27315476</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Collin</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bigley</surname><given-names>V.</given-names></name></person-group> (<year>2018</year>). <article-title>Human dendritic cell subsets: an update</article-title>. <source>Immunology</source><volume>154</volume>, <fpage>3</fpage>&#8211;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1111/imm.12888</pub-id><pub-id pub-id-type="pmid">29313948</pub-id><pub-id pub-id-type="pmcid">PMC5904714</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dam</surname><given-names>T. K.</given-names></name><name name-style="western"><surname>Brewer</surname><given-names>C. F.</given-names></name></person-group> (<year>2008</year>). <article-title>Effects of clustered epitopes in multivalent ligand-receptor interactions</article-title>. <source>Biochemistry</source><volume>47</volume>, <fpage>8470</fpage>&#8211;<lpage>8476</lpage>. <pub-id pub-id-type="doi">10.1021/bi801208b</pub-id><pub-id pub-id-type="pmid">18652478</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dam</surname><given-names>T. K.</given-names></name><name name-style="western"><surname>Brewer</surname><given-names>C. F.</given-names></name></person-group> (<year>2010</year>). <article-title>Lectins as pattern recognition molecules: the effects of epitope density in innate immunity</article-title>. <source>Glycobiology</source><volume>20</volume>, <fpage>270</fpage>&#8211;<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1093/glycob/cwp186</pub-id><pub-id pub-id-type="pmid">19939826</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Jong</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>de Witte</surname><given-names>L.</given-names></name><name name-style="western"><surname>Santegoets</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Fluitsma</surname><given-names>D.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>M. E.</given-names></name><name name-style="western"><surname>de Gruijl</surname><given-names>T. D.</given-names></name><etal/></person-group>. (<year>2010a</year>). <article-title>Mutz-3-derived Langerhans cells are a model to study HIV-1 transmission and potential inhibitors</article-title>. <source>J. Leukoc. Biol.</source><volume>87</volume>, <fpage>637</fpage>&#8211;<lpage>643</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.0809577</pub-id><pub-id pub-id-type="pmid">20042470</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Jong</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Vriend</surname><given-names>L. E.</given-names></name><name name-style="western"><surname>Theelen</surname><given-names>B.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>M. E.</given-names></name><name name-style="western"><surname>Fluitsma</surname><given-names>D.</given-names></name><name name-style="western"><surname>Boekhout</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2010b</year>). <article-title>C-type lectin Langerin is a beta-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi</article-title>. <source>Mol. Immunol.</source><volume>47</volume>, <fpage>1216</fpage>&#8211;<lpage>1225</lpage>. <pub-id pub-id-type="doi">10.1016/j.molimm.2009.12.016</pub-id><pub-id pub-id-type="pmid">20097424</pub-id><pub-id pub-id-type="pmcid">PMC2837148</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deckers</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hammad</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hoste</surname><given-names>E.</given-names></name></person-group> (<year>2018</year>). <article-title>Langerhans cells: sensing the environment in health and disease</article-title>. <source>Front. Immunol.</source><volume>9</volume>:<fpage>93</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.00093</pub-id><pub-id pub-id-type="pmid">29449841</pub-id><pub-id pub-id-type="pmcid">PMC5799717</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Devi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rajakumara</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>N.</given-names></name></person-group> (<year>2015</year>). <article-title>Induction of mincle by helicobacter pylori and consequent anti-inflammatory signaling denote a bacterial survival strategy</article-title>. <source>Sci. Rep.</source><volume>5</volume>:<fpage>15049</fpage>. <pub-id pub-id-type="doi">10.1038/srep15049</pub-id><pub-id pub-id-type="pmid">26456705</pub-id><pub-id pub-id-type="pmcid">PMC4601021</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doebel</surname><given-names>T.</given-names></name><name name-style="western"><surname>Voisin</surname><given-names>B.</given-names></name><name name-style="western"><surname>Nagao</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Langerhans cells - the macrophage in dendritic cell clothing</article-title>. <source>Trends Immunol</source>. <volume>38</volume>, <fpage>817</fpage>&#8211;<lpage>828</lpage>. <pub-id pub-id-type="doi">10.1016/j.it.2017.06.008</pub-id><pub-id pub-id-type="pmid">28720426</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dorr</surname><given-names>T.</given-names></name><name name-style="western"><surname>Moynihan</surname><given-names>P. J.</given-names></name><name name-style="western"><surname>Mayer</surname><given-names>C.</given-names></name></person-group> (<year>2019</year>). <article-title>Editorial: bacterial cell wall structure and dynamics</article-title>. <source>Front. Microbiol.</source><volume>10</volume>:<fpage>2051</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2019.02051</pub-id><pub-id pub-id-type="pmid">31551985</pub-id><pub-id pub-id-type="pmcid">PMC6737391</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Drickamer</surname><given-names>K.</given-names></name></person-group> (<year>1992</year>). <article-title>Engineering galactose-binding activity into a C-type mannose-binding protein</article-title>. <source>Nature</source><volume>360</volume>, <fpage>183</fpage>&#8211;<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1038/360183a0</pub-id><pub-id pub-id-type="pmid">1279438</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Drickamer</surname><given-names>K.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>M. E.</given-names></name></person-group> (<year>2015</year>). <article-title>Recent insights into structures and functions of C-type lectins in the immune system</article-title>. <source>Curr. Opin. Struct. Biol.</source><volume>34</volume>, <fpage>26</fpage>&#8211;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.sbi.2015.06.003</pub-id><pub-id pub-id-type="pmid">26163333</pub-id><pub-id pub-id-type="pmcid">PMC4681411</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edgar</surname><given-names>R. J.</given-names></name><name name-style="western"><surname>van Hensbergen</surname><given-names>V. P.</given-names></name><name name-style="western"><surname>Ruda</surname><given-names>A.</given-names></name><name name-style="western"><surname>Turner</surname><given-names>A. G.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>P.</given-names></name><name name-style="western"><surname>Le Breton</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Discovery of glycerol phosphate modification on streptococcal rhamnose polysaccharides</article-title>. <source>Nat. Chem. Biol.</source><volume>15</volume>, <fpage>463</fpage>&#8211;<lpage>471</lpage>. <pub-id pub-id-type="doi">10.1038/s41589-019-0251-4</pub-id><pub-id pub-id-type="pmid">30936502</pub-id><pub-id pub-id-type="pmcid">PMC6470023</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eriksson</surname><given-names>M.</given-names></name><name name-style="western"><surname>Serna</surname><given-names>S.</given-names></name><name name-style="western"><surname>Maglinao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Schlegel</surname><given-names>M. K.</given-names></name><name name-style="western"><surname>Seeberger</surname><given-names>P. H.</given-names></name><name name-style="western"><surname>Reichardt</surname><given-names>N. C.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Biological evaluation of multivalent lewis X-MGL-1 interactions</article-title>. <source>Chembiochem</source><volume>15</volume>, <fpage>844</fpage>&#8211;<lpage>851</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201300764</pub-id><pub-id pub-id-type="pmid">24616167</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feinberg</surname><given-names>H.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>D. A.</given-names></name><name name-style="western"><surname>Drickamer</surname><given-names>K.</given-names></name><name name-style="western"><surname>Weis</surname><given-names>W. I.</given-names></name></person-group> (<year>2005</year>). <article-title>Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR</article-title>. <source>J. Biol. Chem.</source><volume>280</volume>, <fpage>1327</fpage>&#8211;<lpage>1335</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M409925200</pub-id><pub-id pub-id-type="pmid">15509576</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feinberg</surname><given-names>H.</given-names></name><name name-style="western"><surname>Powlesland</surname><given-names>A. S.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>M. E.</given-names></name><name name-style="western"><surname>Weis</surname><given-names>W. I.</given-names></name></person-group> (<year>2010</year>). <article-title>Trimeric structure of langerin</article-title>. <source>J. Biol. Chem.</source><volume>285</volume>, <fpage>13285</fpage>&#8211;<lpage>13293</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.086058</pub-id><pub-id pub-id-type="pmid">20181944</pub-id><pub-id pub-id-type="pmcid">PMC2857130</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feinberg</surname><given-names>H.</given-names></name><name name-style="western"><surname>Rowntree</surname><given-names>T. J.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>S. L.</given-names></name><name name-style="western"><surname>Drickamer</surname><given-names>K.</given-names></name><name name-style="western"><surname>Weis</surname><given-names>W. I.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>M. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Common polymorphisms in human langerin change specificity for glycan ligands</article-title>. <source>J. Biol. Chem.</source><volume>288</volume>, <fpage>36762</fpage>&#8211;<lpage>36771</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M113.528000</pub-id><pub-id pub-id-type="pmid">24217250</pub-id><pub-id pub-id-type="pmcid">PMC3873535</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feinberg</surname><given-names>H.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>M. E.</given-names></name><name name-style="western"><surname>Razi</surname><given-names>N.</given-names></name><name name-style="western"><surname>McBride</surname><given-names>R.</given-names></name><name name-style="western"><surname>Knirel</surname><given-names>Y. A.</given-names></name><name name-style="western"><surname>Graham</surname><given-names>S. A.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Structural basis for langerin recognition of diverse pathogen and mammalian glycans through a single binding site</article-title>. <source>J. Mol. Biol.</source><volume>405</volume>, <fpage>1027</fpage>&#8211;<lpage>1039</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2010.11.039</pub-id><pub-id pub-id-type="pmid">21112338</pub-id><pub-id pub-id-type="pmcid">PMC3065333</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fernandes</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Finnegan</surname><given-names>A. A.</given-names></name><name name-style="western"><surname>Siracusa</surname><given-names>L. D.</given-names></name><name name-style="western"><surname>Brenner</surname><given-names>C.</given-names></name><name name-style="western"><surname>Iscove</surname><given-names>N. N.</given-names></name><name name-style="western"><surname>Calabretta</surname><given-names>B.</given-names></name></person-group> (<year>1999</year>). <article-title>Characterization of a novel receptor that maps near the natural killer gene complex: demonstration of carbohydrate binding and expression in hematopoietic cells</article-title>. <source>Cancer Res.</source><volume>59</volume>, <fpage>2709</fpage>&#8211;<lpage>2717</lpage>.<pub-id pub-id-type="pmid">10363996</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flacher</surname><given-names>V.</given-names></name><name name-style="western"><surname>Bouschbacher</surname><given-names>M.</given-names></name><name name-style="western"><surname>Verronese</surname><given-names>E.</given-names></name><name name-style="western"><surname>Massacrier</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sisirak</surname><given-names>V.</given-names></name><name name-style="western"><surname>Berthier-Vergnes</surname><given-names>O.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria</article-title>. <source>J. Immunol.</source><volume>177</volume>, <fpage>7959</fpage>&#8211;<lpage>7967</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.177.11.7959</pub-id><pub-id pub-id-type="pmid">17114468</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geijtenbeek</surname><given-names>T. B.</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>D. S.</given-names></name><name name-style="western"><surname>Torensma</surname><given-names>R.</given-names></name><name name-style="western"><surname>van Vliet</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>van Duijnhoven</surname><given-names>G. C.</given-names></name><name name-style="western"><surname>Middel</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2000a</year>). <article-title>DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells</article-title>. <source>Cell</source><volume>100</volume>, <fpage>587</fpage>&#8211;<lpage>597</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)80694-7</pub-id><pub-id pub-id-type="pmid">10721995</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geijtenbeek</surname><given-names>T. B.</given-names></name><name name-style="western"><surname>Torensma</surname><given-names>R.</given-names></name><name name-style="western"><surname>van Vliet</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>van Duijnhoven</surname><given-names>G. C.</given-names></name><name name-style="western"><surname>Adema</surname><given-names>G. J.</given-names></name><name name-style="western"><surname>van Kooyk</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2000b</year>). <article-title>Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses</article-title>. <source>Cell</source><volume>100</volume>, <fpage>575</fpage>&#8211;<lpage>585</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)80693-5</pub-id><pub-id pub-id-type="pmid">10721994</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geissner</surname><given-names>A.</given-names></name><name name-style="western"><surname>Reinhardt</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rademacher</surname><given-names>C.</given-names></name><name name-style="western"><surname>Johannssen</surname><given-names>T.</given-names></name><name name-style="western"><surname>Monteiro</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lepenies</surname><given-names>B.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Microbe-focused glycan array screening platform</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>116</volume>, <fpage>1958</fpage>&#8211;<lpage>1967</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1800853116</pub-id><pub-id pub-id-type="pmid">30670663</pub-id><pub-id pub-id-type="pmcid">PMC6369816</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gerlach</surname><given-names>D.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>De Castro</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S. H.</given-names></name><name name-style="western"><surname>Schlatterer</surname><given-names>K.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>F. F.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic> alters cell wall glycosylation to evade immunity</article-title>. <source>Nature</source><volume>563</volume>, <fpage>705</fpage>&#8211;<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-018-0730-x</pub-id><pub-id pub-id-type="pmid">30464342</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gringhuis</surname><given-names>S. I.</given-names></name><name name-style="western"><surname>den Dunnen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Litjens</surname><given-names>M.</given-names></name><name name-style="western"><surname>van der Vlist</surname><given-names>M.</given-names></name><name name-style="western"><surname>Geijtenbeek</surname><given-names>T. B.</given-names></name></person-group> (<year>2009</year>). <article-title>Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to <italic toggle="yes">Mycobacterium tuberculosis</italic>, HIV-1 and Helicobacter pylori</article-title>. <source>Nat. Immunol.</source><volume>10</volume>, <fpage>1081</fpage>&#8211;<lpage>1088</lpage>. <pub-id pub-id-type="doi">10.1038/ni.1778</pub-id><pub-id pub-id-type="pmid">19718030</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gringhuis</surname><given-names>S. I.</given-names></name><name name-style="western"><surname>Kaptein</surname><given-names>T. M.</given-names></name><name name-style="western"><surname>Wevers</surname><given-names>B. A.</given-names></name><name name-style="western"><surname>Mesman</surname><given-names>A. W.</given-names></name><name name-style="western"><surname>Geijtenbeek</surname><given-names>T. B.</given-names></name></person-group> (<year>2014</year>). <article-title>Fucose-specific DC-SIGN signalling directs T helper cell type-2 responses via IKKepsilon- and CYLD-dependent Bcl3 activation</article-title>. <source>Nat. Commun.</source><volume>5</volume>:<fpage>3898</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms4898</pub-id><pub-id pub-id-type="pmid">24867235</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gunawan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jardine</surname><given-names>L.</given-names></name><name name-style="western"><surname>Haniffa</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Isolation of human skin dendritic cell subsets</article-title>. <source>Methods Mol. Biol.</source><volume>1423</volume>, <fpage>119</fpage>&#8211;<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-3606-9_8</pub-id><pub-id pub-id-type="pmid">27142012</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanske</surname><given-names>J.</given-names></name><name name-style="western"><surname>Aleksic</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ballaschk</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jurk</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shanina</surname><given-names>E.</given-names></name><name name-style="western"><surname>Beerbaum</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Intradomain allosteric network modulates calcium affinity of the C-type lectin receptor langerin</article-title>. <source>J. Am. Chem. Soc.</source><volume>138</volume>, <fpage>12176</fpage>&#8211;<lpage>12186</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.6b05458</pub-id><pub-id pub-id-type="pmid">27560542</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanske</surname><given-names>J.</given-names></name><name name-style="western"><surname>Schulze</surname><given-names>J.</given-names></name><name name-style="western"><surname>Aretz</surname><given-names>J.</given-names></name><name name-style="western"><surname>McBride</surname><given-names>R.</given-names></name><name name-style="western"><surname>Loll</surname><given-names>B.</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Bacterial polysaccharide specificity of the pattern recognition receptor langerin is highly species-dependent</article-title>. <source>J. Biol. Chem.</source><volume>292</volume>, <fpage>862</fpage>&#8211;<lpage>871</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M116.751750</pub-id><pub-id pub-id-type="pmid">27903635</pub-id><pub-id pub-id-type="pmcid">PMC5247659</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harman</surname><given-names>A. N.</given-names></name><name name-style="western"><surname>Bye</surname><given-names>C. R.</given-names></name><name name-style="western"><surname>Nasr</surname><given-names>N.</given-names></name><name name-style="western"><surname>Sandgren</surname><given-names>K. J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mercier</surname><given-names>S. K.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Identification of lineage relationships and novel markers of blood and skin human dendritic cells</article-title>. <source>J. Immunol.</source><volume>190</volume>, <fpage>66</fpage>&#8211;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1200779</pub-id><pub-id pub-id-type="pmid">23183897</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>Y. X.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>C. L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Park</surname><given-names>C. G.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title><italic toggle="yes">Yersinia pseudotuberculosis</italic> exploits CD209 receptors for promoting host dissemination and infection</article-title>. <source>Infect. Immun</source>. <volume>87</volume>:<fpage>e00654</fpage>&#8211;<lpage>1</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00654-18</pub-id><pub-id pub-id-type="pmid">30348825</pub-id><pub-id pub-id-type="pmcid">PMC6300620</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heger</surname><given-names>L.</given-names></name><name name-style="western"><surname>Balk</surname><given-names>S.</given-names></name><name name-style="western"><surname>Luhr</surname><given-names>J. J.</given-names></name><name name-style="western"><surname>Heidkamp</surname><given-names>G. F.</given-names></name><name name-style="western"><surname>Lehmann</surname><given-names>C. H. K.</given-names></name><name name-style="western"><surname>Hatscher</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>CLEC10A Is a specific marker for human CD1c(+) dendritic cells and enhances their toll-like receptor 7/8-induced cytokine secretion</article-title>. <source>Front. Immunol.</source><volume>9</volume>:<fpage>744</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.00744</pub-id><pub-id pub-id-type="pmid">29755453</pub-id><pub-id pub-id-type="pmcid">PMC5934495</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hossain</surname><given-names>M. K.</given-names></name><name name-style="western"><surname>Wall</surname><given-names>K. A.</given-names></name></person-group> (<year>2019</year>). <article-title>Use of dendritic cell receptors as targets for enhancing anti-cancer immune responses</article-title>. <source>Cancers</source><volume>11</volume>:<fpage>418</fpage>. <pub-id pub-id-type="doi">10.3390/cancers11030418</pub-id><pub-id pub-id-type="pmid">30909630</pub-id><pub-id pub-id-type="pmcid">PMC6469018</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoving</surname><given-names>J. C.</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>G. J.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>G. D.</given-names></name></person-group> (<year>2014</year>). <article-title>Signalling C-type lectin receptors, microbial recognition and immunity</article-title>. <source>Cell. Microbiol.</source><volume>16</volume>, <fpage>185</fpage>&#8211;<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1111/cmi.12249</pub-id><pub-id pub-id-type="pmid">24330199</pub-id><pub-id pub-id-type="pmcid">PMC4016756</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsu</surname><given-names>K. L.</given-names></name><name name-style="western"><surname>Mahal</surname><given-names>L. K.</given-names></name></person-group> (<year>2009</year>). <article-title>Sweet tasting chips: microarray-based analysis of glycans</article-title>. <source>Curr. Opin. Chem. Biol.</source><volume>13</volume>, <fpage>427</fpage>&#8211;<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2009.07.013</pub-id><pub-id pub-id-type="pmid">19716334</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsu</surname><given-names>K. L.</given-names></name><name name-style="western"><surname>Pilobello</surname><given-names>K. T.</given-names></name><name name-style="western"><surname>Mahal</surname><given-names>L. K.</given-names></name></person-group> (<year>2006</year>). <article-title>Analyzing the dynamic bacterial glycome with a lectin microarray approach</article-title>. <source>Nat. Chem. Biol.</source><volume>2</volume>, <fpage>153</fpage>&#8211;<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio767</pub-id><pub-id pub-id-type="pmid">16462751</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsu</surname><given-names>T. L.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>S. C.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>W. B.</given-names></name><name name-style="western"><surname>Chin</surname><given-names>S. W.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>B. H.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>M. T.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Profiling carbohydrate-receptor interaction with recombinant innate immunity receptor-Fc fusion proteins</article-title>. <source>J. Biol. Chem.</source><volume>284</volume>, <fpage>34479</fpage>&#8211;<lpage>34489</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.065961</pub-id><pub-id pub-id-type="pmid">19837675</pub-id><pub-id pub-id-type="pmcid">PMC2787309</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iborra</surname><given-names>S.</given-names></name><name name-style="western"><surname>Martinez-Lopez</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cueto</surname><given-names>F. J.</given-names></name><name name-style="western"><surname>Conde-Garrosa</surname><given-names>R.</given-names></name><name name-style="western"><surname>Del Fresno</surname><given-names>C.</given-names></name><name name-style="western"><surname>Izquierdo</surname><given-names>H. M.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Leishmania uses mincle to target an inhibitory ITAM signaling pathway in dendritic cells that dampens adaptive immunity to infection</article-title>. <source>Immunity</source><volume>45</volume>, <fpage>788</fpage>&#8211;<lpage>801</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2016.09.012</pub-id><pub-id pub-id-type="pmid">27742545</pub-id><pub-id pub-id-type="pmcid">PMC5074365</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Imai</surname><given-names>T.</given-names></name><name name-style="western"><surname>Matsumura</surname><given-names>T.</given-names></name><name name-style="western"><surname>Mayer-Lambertz</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wells</surname><given-names>C. A.</given-names></name><name name-style="western"><surname>Ishikawa</surname><given-names>E.</given-names></name><name name-style="western"><surname>Butcher</surname><given-names>S. K.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Lipoteichoic acid anchor triggers Mincle to drive protective immunity against invasive group A <italic toggle="yes">Streptococcus</italic> infection</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>115</volume>, <fpage>E10662</fpage>&#8211;<lpage>E10671</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1809100115</pub-id><pub-id pub-id-type="pmid">30352847</pub-id><pub-id pub-id-type="pmcid">PMC6233082</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jahnsen</surname><given-names>F. L.</given-names></name><name name-style="western"><surname>Strickland</surname><given-names>D. H.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Tobagus</surname><given-names>I. T.</given-names></name><name name-style="western"><surname>Napoli</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zosky</surname><given-names>G. R.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>Accelerated antigen sampling and transport by airway mucosal dendritic cells following inhalation of a bacterial stimulus</article-title>. <source>J. Immunol.</source><volume>177</volume>, <fpage>5861</fpage>&#8211;<lpage>5867</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.177.9.5861</pub-id><pub-id pub-id-type="pmid">17056510</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Janela</surname><given-names>B.</given-names></name><name name-style="western"><surname>Patel</surname><given-names>A. A.</given-names></name><name name-style="western"><surname>Lau</surname><given-names>M. C.</given-names></name><name name-style="western"><surname>Goh</surname><given-names>C. C.</given-names></name><name name-style="western"><surname>Msallam</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kong</surname><given-names>W. T.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>A subset of type I conventional dendritic cells controls cutaneous bacterial infections through VEGFalpha-mediated recruitment of neutrophils</article-title>. <source>Immunity</source><volume>50</volume>, <fpage>1069</fpage>&#8211;<lpage>1083.e1068</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2019.03.001</pub-id><pub-id pub-id-type="pmid">30926233</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jegouzo</surname><given-names>S. A.</given-names></name><name name-style="western"><surname>Quintero-Martinez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ouyang</surname><given-names>X.</given-names></name><name name-style="western"><surname>dos Santos</surname><given-names>A.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>M. E.</given-names></name><name name-style="western"><surname>Drickamer</surname><given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>Organization of the extracellular portion of the macrophage galactose receptor: a trimeric cluster of simple binding sites for N-acetylgalactosamine</article-title>. <source>Glycobiology</source><volume>23</volume>, <fpage>853</fpage>&#8211;<lpage>864</lpage>. <pub-id pub-id-type="doi">10.1093/glycob/cwt022</pub-id><pub-id pub-id-type="pmid">23507965</pub-id><pub-id pub-id-type="pmcid">PMC3671775</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kawata</surname><given-names>K.</given-names></name><name name-style="western"><surname>Illarionov</surname><given-names>P.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>G. X.</given-names></name><name name-style="western"><surname>Kenny</surname><given-names>T. P.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Tsuda</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Mincle and human B cell function</article-title>. <source>J. Autoimmun.</source><volume>39</volume>, <fpage>315</fpage>&#8211;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaut.2012.04.004</pub-id><pub-id pub-id-type="pmid">22698596</pub-id><pub-id pub-id-type="pmcid">PMC3443704</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kostarnoy</surname><given-names>A. V.</given-names></name><name name-style="western"><surname>Gancheva</surname><given-names>P. G.</given-names></name><name name-style="western"><surname>Lepenies</surname><given-names>B.</given-names></name><name name-style="western"><surname>Tukhvatulin</surname><given-names>A. I.</given-names></name><name name-style="western"><surname>Dzharullaeva</surname><given-names>A. S.</given-names></name><name name-style="western"><surname>Polyakov</surname><given-names>N. B.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Receptor mincle promotes skin allergies and is capable of recognizing cholesterol sulfate</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>114</volume>, <fpage>E2758</fpage>&#8211;<lpage>E2765</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1611665114</pub-id><pub-id pub-id-type="pmid">28292894</pub-id><pub-id pub-id-type="pmcid">PMC5380039</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kubo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nagao</surname><given-names>K.</given-names></name><name name-style="western"><surname>Yokouchi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sasaki</surname><given-names>H.</given-names></name><name name-style="western"><surname>Amagai</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers</article-title>. <source>J. Exp. Med.</source><volume>206</volume>, <fpage>2937</fpage>&#8211;<lpage>2946</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20091527</pub-id><pub-id pub-id-type="pmid">19995951</pub-id><pub-id pub-id-type="pmcid">PMC2806471</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Schoenen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Desel</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Targeting Syk-Card9-activating C-type lectin receptors by vaccine adjuvants: findings, implications and open questions</article-title>. <source>Immunobiology</source><volume>216</volume>, <fpage>1184</fpage>&#8211;<lpage>1191</lpage>. <pub-id pub-id-type="doi">10.1016/j.imbio.2011.06.005</pub-id><pub-id pub-id-type="pmid">21742403</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lepenies</surname><given-names>B.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sonkaria</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Targeting C-type lectin receptors with multivalent carbohydrate ligands</article-title>. <source>Adv. Drug Deliv. Rev.</source><volume>65</volume>, <fpage>1271</fpage>&#8211;<lpage>1281</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2013.05.007</pub-id><pub-id pub-id-type="pmid">23727341</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lewis</surname><given-names>A. L.</given-names></name><name name-style="western"><surname>Nizet</surname><given-names>V.</given-names></name><name name-style="western"><surname>Varki</surname><given-names>A.</given-names></name></person-group> (<year>2004</year>). <article-title>Discovery and characterization of sialic acid O-acetylation in group B <italic toggle="yes">Streptococcus</italic></article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>101</volume>, <fpage>11123</fpage>&#8211;<lpage>11128</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0403010101</pub-id><pub-id pub-id-type="pmid">15263085</pub-id><pub-id pub-id-type="pmcid">PMC503750</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>R. E.</given-names></name><name name-style="western"><surname>Hogervorst</surname><given-names>T. P.</given-names></name><name name-style="western"><surname>Achilli</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bruijns</surname><given-names>S. C.</given-names></name><name name-style="western"><surname>Arnoldus</surname><given-names>T.</given-names></name><name name-style="western"><surname>Vives</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Systematic dual targeting of dendritic cell C-type lectin receptor DC-SIGN and TLR7 using a trifunctional mannosylated antigen</article-title>. <source>Front. Chem.</source><volume>7</volume>:<fpage>650</fpage>. <pub-id pub-id-type="doi">10.3389/fchem.2019.00650</pub-id><pub-id pub-id-type="pmid">31637232</pub-id><pub-id pub-id-type="pmcid">PMC6787163</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>T. H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Hou</surname><given-names>Y. Y.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>S. N.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T. T.</given-names></name></person-group> (<year>2019</year>). <article-title>C-type lectin receptor-mediated immune recognition and response of the microbiota in the gut</article-title>. <source>Gastroenterol. Rep.</source><volume>7</volume>, <fpage>312</fpage>&#8211;<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1093/gastro/goz028</pub-id><pub-id pub-id-type="pmid">31687150</pub-id><pub-id pub-id-type="pmcid">PMC6821170</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>C. H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ge</surname><given-names>B.</given-names></name></person-group> (<year>2017</year>). <article-title>Innate immunity in tuberculosis: host defense vs pathogen evasion</article-title>. <source>Cell. Mol. Immunol.</source><volume>14</volume>, <fpage>963</fpage>&#8211;<lpage>975</lpage>. <pub-id pub-id-type="doi">10.1038/cmi.2017.88</pub-id><pub-id pub-id-type="pmid">28890547</pub-id><pub-id pub-id-type="pmcid">PMC5719146</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lobato-Pascual</surname><given-names>A.</given-names></name><name name-style="western"><surname>Saether</surname><given-names>P. C.</given-names></name><name name-style="western"><surname>Fossum</surname><given-names>S.</given-names></name><name name-style="western"><surname>Dissen</surname><given-names>E.</given-names></name><name name-style="western"><surname>Daws</surname><given-names>M. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Mincle, the receptor for mycobacterial cord factor, forms a functional receptor complex with MCL and FcepsilonRI-gamma</article-title>. <source>Eur. J. Immunol.</source><volume>43</volume>, <fpage>3167</fpage>&#8211;<lpage>3174</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201343752</pub-id><pub-id pub-id-type="pmid">23921530</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Nagata</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yamasaki</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Mincle: 20 years of a versatile sensor of insults</article-title>. <source>Int. Immunol.</source><volume>30</volume>, <fpage>233</fpage>&#8211;<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1093/intimm/dxy028</pub-id><pub-id pub-id-type="pmid">29726997</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lundberg</surname><given-names>A. H.</given-names></name><name name-style="western"><surname>Fukatsu</surname><given-names>K.</given-names></name><name name-style="western"><surname>Gaber</surname><given-names>L.</given-names></name><name name-style="western"><surname>Callicutt</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kotb</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wilcox</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2001</year>). <article-title>Blocking pulmonary ICAM-1 expression ameliorates lung injury in established diet-induced pancreatitis</article-title>. <source>Ann. Surg.</source><volume>233</volume>, <fpage>213</fpage>&#8211;<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1097/00000658-200102000-00010</pub-id><pub-id pub-id-type="pmid">11176127</pub-id><pub-id pub-id-type="pmcid">PMC1421203</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lundberg</surname><given-names>K.</given-names></name><name name-style="western"><surname>Albrekt</surname><given-names>A. S.</given-names></name><name name-style="western"><surname>Nelissen</surname><given-names>I.</given-names></name><name name-style="western"><surname>Santegoets</surname><given-names>S.</given-names></name><name name-style="western"><surname>de Gruijl</surname><given-names>T. D.</given-names></name><name name-style="western"><surname>Gibbs</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Transcriptional profiling of human dendritic cell populations and models&#8211;unique profiles of <italic toggle="yes">in vitro</italic> dendritic cells and implications on functionality and applicability</article-title>. <source>PLoS ONE</source><volume>8</volume>:<fpage>e52875</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0052875</pub-id><pub-id pub-id-type="pmid">23341914</pub-id><pub-id pub-id-type="pmcid">PMC3544800</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maalej</surname><given-names>M. M.</given-names></name><name name-style="western"><surname>Forgione</surname><given-names>R. E.</given-names></name><name name-style="western"><surname>Marchetti</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bulteau</surname><given-names>F. B.</given-names></name><name name-style="western"><surname>Thepaut</surname><given-names>M. T.</given-names></name><name name-style="western"><surname>Lanzetta</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>The human macrophage galactose-type lectin, MGL, recognizes the outer core of <italic toggle="yes">E. coli</italic> lipooligosaccharide</article-title>. <source>Chembiochem</source><volume>20</volume>, <fpage>1778</fpage>&#8211;<lpage>1782</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201900087</pub-id><pub-id pub-id-type="pmid">30919527</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mader</surname><given-names>U.</given-names></name><name name-style="western"><surname>Nicolas</surname><given-names>P.</given-names></name><name name-style="western"><surname>Depke</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pane-Farre</surname><given-names>J.</given-names></name><name name-style="western"><surname>Debarbouille</surname><given-names>M.</given-names></name><name name-style="western"><surname>van der Kooi-Pol</surname><given-names>M. M.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title><italic toggle="yes">Staphylococcus aureus</italic> transcriptome architecture: from laboratory to infection-mimicking conditions</article-title>. <source>PLoS Genet.</source><volume>12</volume>:<fpage>e1005962</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1005962</pub-id><pub-id pub-id-type="pmid">27035918</pub-id><pub-id pub-id-type="pmcid">PMC4818034</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maglinao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Eriksson</surname><given-names>M.</given-names></name><name name-style="western"><surname>Schlegel</surname><given-names>M. K.</given-names></name><name name-style="western"><surname>Zimmermann</surname><given-names>S.</given-names></name><name name-style="western"><surname>Johannssen</surname><given-names>T.</given-names></name><name name-style="western"><surname>Gotze</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>A platform to screen for C-type lectin receptor-binding carbohydrates and their potential for cell-specific targeting and immune modulation</article-title>. <source>J. Control. Release</source><volume>175</volume>, <fpage>36</fpage>&#8211;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2013.12.011</pub-id><pub-id pub-id-type="pmid">24368301</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mairpady Shambat</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P.</given-names></name><name name-style="western"><surname>Nguyen Hoang</surname><given-names>A. T.</given-names></name><name name-style="western"><surname>Bergsten</surname><given-names>H.</given-names></name><name name-style="western"><surname>Vandenesch</surname><given-names>F.</given-names></name><name name-style="western"><surname>Siemens</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Modelling staphylococcal pneumonia in a human 3D lung tissue model system delineates toxin-mediated pathology</article-title>. <source>Dis. Model. Mech.</source><volume>8</volume>, <fpage>1413</fpage>&#8211;<lpage>1425</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.021923</pub-id><pub-id pub-id-type="pmid">26398950</pub-id><pub-id pub-id-type="pmcid">PMC4631791</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marcelo</surname><given-names>F.</given-names></name><name name-style="western"><surname>Garcia-Martin</surname><given-names>F.</given-names></name><name name-style="western"><surname>Matsushita</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sardinha</surname><given-names>J.</given-names></name><name name-style="western"><surname>Coelho</surname><given-names>H.</given-names></name><name name-style="western"><surname>Oude-Vrielink</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Delineating binding modes of Gal/GalNAc and structural elements of the molecular recognition of tumor-associated mucin glycopeptides by the human macrophage galactose-type lectin</article-title>. <source>Chemistry</source><volume>20</volume>, <fpage>16147</fpage>&#8211;<lpage>16155</lpage>. <pub-id pub-id-type="doi">10.1002/chem.201404566</pub-id><pub-id pub-id-type="pmid">25324212</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masterson</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Sombroek</surname><given-names>C. C.</given-names></name><name name-style="western"><surname>De Gruijl</surname><given-names>T. D.</given-names></name><name name-style="western"><surname>Graus</surname><given-names>Y. M.</given-names></name><name name-style="western"><surname>van der Vliet</surname><given-names>H. J.</given-names></name><name name-style="western"><surname>Lougheed</surname><given-names>S. M.</given-names></name><etal/></person-group>. (<year>2002</year>). <article-title>MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors</article-title>. <source>Blood</source><volume>100</volume>, <fpage>701</fpage>&#8211;<lpage>703</lpage>. <pub-id pub-id-type="doi">10.1182/blood.V100.2.701</pub-id><pub-id pub-id-type="pmid">12091369</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsumoto</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kaisho</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sanjo</surname><given-names>H.</given-names></name><name name-style="western"><surname>Copeland</surname><given-names>N. G.</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>D. J.</given-names></name><etal/></person-group>. (<year>1999</year>). <article-title>A novel LPS-inducible C-type lectin is a transcriptional target of NF-IL6 in macrophages</article-title>. <source>J. Immunol.</source><volume>163</volume>, <fpage>5039</fpage>&#8211;<lpage>5048</lpage>.<pub-id pub-id-type="pmid">10528209</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsumura</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ikebe</surname><given-names>T.</given-names></name><name name-style="western"><surname>Arikawa</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hosokawa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Aiko</surname><given-names>M.</given-names></name><name name-style="western"><surname>Iguchi</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Sequential sensing by TLR2 and mincle directs immature myeloid cells to protect against invasive group A streptococcal infection in mice</article-title>. <source>Cell Rep.</source><volume>27</volume>, <fpage>561</fpage>&#8211;<lpage>571.e566</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2019.03.056</pub-id><pub-id pub-id-type="pmid">30970258</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mayer</surname><given-names>S.</given-names></name><name name-style="western"><surname>Moeller</surname><given-names>R.</given-names></name><name name-style="western"><surname>Monteiro</surname><given-names>J. T.</given-names></name><name name-style="western"><surname>Ellrott</surname><given-names>K.</given-names></name><name name-style="western"><surname>Josenhans</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lepenies</surname><given-names>B.</given-names></name></person-group> (<year>2018</year>). <article-title>C-Type Lectin Receptor (CLR)-Fc fusion proteins as tools to screen for novel CLR/bacteria interactions: an exemplary study on preselected <italic toggle="yes">Campylobacter jejuni</italic> isolates</article-title>. <source>Front. Immunol.</source><volume>9</volume>:<fpage>213</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.00213</pub-id><pub-id pub-id-type="pmid">29487596</pub-id><pub-id pub-id-type="pmcid">PMC5816833</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Medzhitov</surname><given-names>R.</given-names></name><name name-style="western"><surname>Janeway</surname><given-names>C. A.</given-names><suffix>Jr.</suffix></name></person-group> (<year>2002</year>). <article-title>Decoding the patterns of self and nonself by the innate immune system</article-title>. <source>Science</source><volume>296</volume>, <fpage>298</fpage>&#8211;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1126/science.1068883</pub-id><pub-id pub-id-type="pmid">11951031</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitchell</surname><given-names>D. A.</given-names></name><name name-style="western"><surname>Fadden</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Drickamer</surname><given-names>K.</given-names></name></person-group> (<year>2001</year>). <article-title>A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands</article-title>. <source>J. Biol. Chem.</source><volume>276</volume>, <fpage>28939</fpage>&#8211;<lpage>28945</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M104565200</pub-id><pub-id pub-id-type="pmid">11384997</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mizoguchi</surname><given-names>I.</given-names></name><name name-style="western"><surname>Ohashi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chiba</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hasegawa</surname><given-names>H.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Owaki</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Prediction of chemical respiratory and contact sensitizers by OX40L expression in dendritic cells using a novel 3D coculture system</article-title>. <source>Front. Immunol.</source><volume>8</volume>:<fpage>929</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.00929</pub-id><pub-id pub-id-type="pmid">28824649</pub-id><pub-id pub-id-type="pmcid">PMC5543289</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mnich</surname><given-names>M. E.</given-names></name><name name-style="western"><surname>van Dalen</surname><given-names>R.</given-names></name><name name-style="western"><surname>Gerlach</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hendriks</surname><given-names>A.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>G.</given-names></name><name name-style="western"><surname>Peschel</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>The C-type lectin receptor MGL senses N-acetylgalactosamine on the unique <italic toggle="yes">Staphylococcus aureus</italic> ST395 wall teichoic acid</article-title>. <source>Cell. Microbiol.</source><volume>21</volume>:<fpage>e13072</fpage>. <pub-id pub-id-type="doi">10.1111/cmi.13072</pub-id><pub-id pub-id-type="pmid">31219660</pub-id><pub-id pub-id-type="pmcid">PMC6771913</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakatsuji</surname><given-names>T.</given-names></name><name name-style="western"><surname>Chiang</surname><given-names>H. I.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>S. B.</given-names></name><name name-style="western"><surname>Nagarajan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zengler</surname><given-names>K.</given-names></name><name name-style="western"><surname>Gallo</surname><given-names>R. L.</given-names></name></person-group> (<year>2013</year>). <article-title>The microbiome extends to subepidermal compartments of normal skin</article-title>. <source>Nat. Commun.</source><volume>4</volume>:<fpage>1431</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms2441</pub-id><pub-id pub-id-type="pmid">23385576</pub-id><pub-id pub-id-type="pmcid">PMC3655727</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neuhaus</surname><given-names>K.</given-names></name><name name-style="western"><surname>Wamhoff</surname><given-names>E. C.</given-names></name><name name-style="western"><surname>Freichel</surname><given-names>T.</given-names></name><name name-style="western"><surname>Grafmuller</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rademacher</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hartmann</surname><given-names>L.</given-names></name></person-group> (<year>2019</year>). <article-title>Asymmetrically branched precision glycooligomers targeting langerin</article-title>. <source>Biomacromolecules</source><volume>20</volume>, <fpage>4088</fpage>&#8211;<lpage>4095</lpage>. <pub-id pub-id-type="doi">10.1021/acs.biomac.9b00906</pub-id><pub-id pub-id-type="pmid">31600054</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neumann</surname><given-names>A. K.</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>N. L.</given-names></name><name name-style="western"><surname>Jacobson</surname><given-names>K.</given-names></name></person-group> (<year>2008</year>). <article-title>Distribution and lateral mobility of DC-SIGN on immature dendritic cells&#8211;implications for pathogen uptake</article-title>. <source>J. Cell Sci</source>. <volume>121</volume>, <fpage>634</fpage>&#8211;<lpage>643</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.022418</pub-id><pub-id pub-id-type="pmid">18270264</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niess</surname><given-names>J. H.</given-names></name><name name-style="western"><surname>Brand</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Landsman</surname><given-names>L.</given-names></name><name name-style="western"><surname>Jung</surname><given-names>S.</given-names></name><name name-style="western"><surname>McCormick</surname><given-names>B. A.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance</article-title>. <source>Science</source><volume>307</volume>, <fpage>254</fpage>&#8211;<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1126/science.1102901</pub-id><pub-id pub-id-type="pmid">15653504</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nordenfelt</surname><given-names>P.</given-names></name><name name-style="western"><surname>Bjorck</surname><given-names>L.</given-names></name></person-group> (<year>2013</year>). <article-title>IgG-binding bacterial proteins and pathogenesis</article-title>. <source>Future Microbiol.</source><volume>8</volume>, <fpage>299</fpage>&#8211;<lpage>301</lpage>. <pub-id pub-id-type="doi">10.2217/fmb.13.6</pub-id><pub-id pub-id-type="pmid">23464367</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olaniyi</surname><given-names>R. O.</given-names></name><name name-style="western"><surname>Pancotto</surname><given-names>L.</given-names></name><name name-style="western"><surname>Grimaldi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bagnoli</surname><given-names>F.</given-names></name></person-group> (<year>2018</year>). <article-title>Deciphering the pathological role of staphylococcal alpha-toxin and panton-valentine leukocidin using a novel <italic toggle="yes">ex vivo</italic> human skin model</article-title>. <source>Front. Immunol.</source><volume>9</volume>:<fpage>951</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.00951</pub-id><pub-id pub-id-type="pmid">29867940</pub-id><pub-id pub-id-type="pmcid">PMC5953321</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ouchi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kubo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yokouchi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Adachi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kitashima</surname><given-names>D. Y.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Langerhans cell antigen capture through tight junctions confers preemptive immunity in experimental staphylococcal scalded skin syndrome</article-title>. <source>J. Exp. Med.</source><volume>208</volume>, <fpage>2607</fpage>&#8211;<lpage>2613</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20111718</pub-id><pub-id pub-id-type="pmid">22143886</pub-id><pub-id pub-id-type="pmcid">PMC3244045</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>V. I.</given-names></name><name name-style="western"><surname>Metcalf</surname><given-names>J. P.</given-names></name></person-group> (<year>2018</year>). <article-title>Airway macrophage and dendritic cell subsets in the resting human lung</article-title>. <source>Crit. Rev. Immunol.</source><volume>38</volume>, <fpage>303</fpage>&#8211;<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1615/CritRevImmunol.2018026459</pub-id><pub-id pub-id-type="pmid">30806245</pub-id><pub-id pub-id-type="pmcid">PMC6392073</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patterson</surname><given-names>B. K.</given-names></name><name name-style="western"><surname>Landay</surname><given-names>A.</given-names></name><name name-style="western"><surname>Siegel</surname><given-names>J. N.</given-names></name><name name-style="western"><surname>Flener</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Pessis</surname><given-names>D.</given-names></name><name name-style="western"><surname>Chaviano</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2002</year>). <article-title>Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture</article-title>. <source>Am. J. Pathol.</source><volume>161</volume>, <fpage>867</fpage>&#8211;<lpage>873</lpage>. <pub-id pub-id-type="doi">10.1016/S0002-9440(10)64247-2</pub-id><pub-id pub-id-type="pmid">12213715</pub-id><pub-id pub-id-type="pmcid">PMC1867269</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Porkolab</surname><given-names>V.</given-names></name><name name-style="western"><surname>Chabrol</surname><given-names>E.</given-names></name><name name-style="western"><surname>Varga</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ordanini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sutkeviciu Te</surname><given-names>I.</given-names></name><name name-style="western"><surname>Thepaut</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Rational-differential design of highly specific glycomimetic ligands: targeting DC-SIGN and excluding langerin recognition</article-title>. <source>ACS Chem. Biol.</source><volume>13</volume>, <fpage>600</fpage>&#8211;<lpage>608</lpage>. <pub-id pub-id-type="doi">10.1021/acschembio.7b00958</pub-id><pub-id pub-id-type="pmid">29272097</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prado Acosta</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lepenies</surname><given-names>B.</given-names></name></person-group> (<year>2019</year>). <article-title>Bacterial glycans and their interactions with lectins in the innate immune system</article-title>. <source>Biochem. Soc. Trans.</source><volume>47</volume>, <fpage>1569</fpage>&#8211;<lpage>1579</lpage>. <pub-id pub-id-type="doi">10.1042/BST20170410</pub-id><pub-id pub-id-type="pmid">31724699</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pupovac</surname><given-names>A.</given-names></name><name name-style="western"><surname>Senturk</surname><given-names>B.</given-names></name><name name-style="western"><surname>Griffoni</surname><given-names>C.</given-names></name><name name-style="western"><surname>Maniura-Weber</surname><given-names>K.</given-names></name><name name-style="western"><surname>Rottmar</surname><given-names>M.</given-names></name><name name-style="western"><surname>McArthur</surname><given-names>S. L.</given-names></name></person-group> (<year>2018</year>). <article-title>Toward Immunocompetent 3D Skin Models</article-title>. <source>Adv. Healthc. Mater.</source><volume>7</volume>:<fpage>e1701405</fpage>. <pub-id pub-id-type="doi">10.1002/adhm.201701405</pub-id><pub-id pub-id-type="pmid">29542274</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quaresma</surname><given-names>J. A. S.</given-names></name></person-group> (<year>2019</year>). <article-title>Organization of the skin immune system and compartmentalized immune responses in infectious diseases</article-title>. <source>Clin. Microbiol. Rev.</source><volume>32</volume>:<fpage>e00034</fpage>&#8211;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00034-18</pub-id><pub-id pub-id-type="pmid">31366611</pub-id><pub-id pub-id-type="pmcid">PMC6750136</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raes</surname><given-names>G.</given-names></name><name name-style="western"><surname>Brys</surname><given-names>L.</given-names></name><name name-style="western"><surname>Dahal</surname><given-names>B. K.</given-names></name><name name-style="western"><surname>Brandt</surname><given-names>J.</given-names></name><name name-style="western"><surname>Grooten</surname><given-names>J.</given-names></name><name name-style="western"><surname>Brombacher</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation</article-title>. <source>J. Leukoc. Biol.</source><volume>77</volume>, <fpage>321</fpage>&#8211;<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.0304212</pub-id><pub-id pub-id-type="pmid">15591125</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rappuoli</surname><given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>Glycoconjugate vaccines: principles and mechanisms</article-title>. <source>Sci. Transl. Med.</source><volume>10</volume>:<fpage>eaat4615</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aat4615</pub-id><pub-id pub-id-type="pmid">30158151</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rathinam</surname><given-names>V. A.</given-names></name><name name-style="western"><surname>Appledorn</surname><given-names>D. M.</given-names></name><name name-style="western"><surname>Hoag</surname><given-names>K. A.</given-names></name><name name-style="western"><surname>Amalfitano</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mansfield</surname><given-names>L. S.</given-names></name></person-group> (<year>2009</year>). <article-title><italic toggle="yes">Campylobacter jejuni-</italic>induced activation of dendritic cells involves cooperative signaling through toll-like receptor 4 (TLR4)-MyD88 and TLR4-TRIF axes</article-title>. <source>Infect. Immun.</source><volume>77</volume>, <fpage>2499</fpage>&#8211;<lpage>2507</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.01562-08</pub-id><pub-id pub-id-type="pmid">19332531</pub-id><pub-id pub-id-type="pmcid">PMC2687361</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reed</surname><given-names>W. P.</given-names></name><name name-style="western"><surname>Metzler</surname><given-names>C.</given-names></name><name name-style="western"><surname>Albright</surname><given-names>E.</given-names></name></person-group> (<year>1994</year>). <article-title>Streptococcal adherence to Langerhans cells: a possible step in the pathogenesis of streptococcal pharyngitis</article-title>. <source>Clin. Immunol. Immunopathol.</source><volume>70</volume>, <fpage>28</fpage>&#8211;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1006/clin.1994.1006</pub-id><pub-id pub-id-type="pmid">8261666</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Regnier</surname><given-names>M.</given-names></name><name name-style="western"><surname>Patwardhan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Scheynius</surname><given-names>A.</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>R.</given-names></name></person-group> (<year>1998</year>). <article-title>Reconstructed human epidermis composed of keratinocytes, melanocytes and langerhans cells</article-title>. <source>Med. Biol. Eng. Comput.</source><volume>36</volume>, <fpage>821</fpage>&#8211;<lpage>824</lpage>. <pub-id pub-id-type="doi">10.1007/BF02518889</pub-id><pub-id pub-id-type="pmid">10367476</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rescigno</surname><given-names>M.</given-names></name><name name-style="western"><surname>Urbano</surname><given-names>M.</given-names></name><name name-style="western"><surname>Valzasina</surname><given-names>B.</given-names></name><name name-style="western"><surname>Francolini</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rotta</surname><given-names>G.</given-names></name><name name-style="western"><surname>Bonasio</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2001</year>). <article-title>Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria</article-title>. <source>Nat. Immunol.</source><volume>2</volume>, <fpage>361</fpage>&#8211;<lpage>367</lpage>. <pub-id pub-id-type="doi">10.1038/86373</pub-id><pub-id pub-id-type="pmid">11276208</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rillahan</surname><given-names>C. D.</given-names></name><name name-style="western"><surname>Paulson</surname><given-names>J. C.</given-names></name></person-group> (<year>2011</year>). <article-title>Glycan microarrays for decoding the glycome</article-title>. <source>Annu. Rev. Biochem.</source><volume>80</volume>, <fpage>797</fpage>&#8211;<lpage>823</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-biochem-061809-152236</pub-id><pub-id pub-id-type="pmid">21469953</pub-id><pub-id pub-id-type="pmcid">PMC3116967</pub-id></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saijo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ikeda</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yamabe</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kakuta</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ishigame</surname><given-names>H.</given-names></name><name name-style="western"><surname>Akitsu</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans</article-title>. <source>Immunity</source><volume>32</volume>, <fpage>681</fpage>&#8211;<lpage>691</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2010.05.001</pub-id><pub-id pub-id-type="pmid">20493731</pub-id></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santegoets</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Masterson</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>van der Sluis</surname><given-names>P. C.</given-names></name><name name-style="western"><surname>Lougheed</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Fluitsma</surname><given-names>D. M.</given-names></name><name name-style="western"><surname>van den Eertwegh</surname><given-names>A. J.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>A CD34(+) human cell line model of myeloid dendritic cell differentiation: evidence for a CD14(+)CD11b(+) Langerhans cell precursor</article-title>. <source>J. Leukoc. Biol.</source><volume>80</volume>, <fpage>1337</fpage>&#8211;<lpage>1344</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.0206111</pub-id><pub-id pub-id-type="pmid">16959899</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sato</surname><given-names>K.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X. L.</given-names></name><name name-style="western"><surname>Yudate</surname><given-names>T.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>J. S.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Luby-Phelps</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor gamma chain to induce innate immune responses</article-title>. <source>J. Biol. Chem.</source><volume>281</volume>, <fpage>38854</fpage>&#8211;<lpage>38866</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M606542200</pub-id><pub-id pub-id-type="pmid">17050534</pub-id></mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schaudinn</surname><given-names>C.</given-names></name><name name-style="western"><surname>Dittmann</surname><given-names>C.</given-names></name><name name-style="western"><surname>Jurisch</surname><given-names>J.</given-names></name><name name-style="western"><surname>Laue</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gunday-Tureli</surname><given-names>N.</given-names></name><name name-style="western"><surname>Blume-Peytavi</surname><given-names>U.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Development, standardization and testing of a bacterial wound infection model based on <italic toggle="yes">ex vivo</italic> human skin</article-title>. <source>PLoS ONE</source><volume>12</volume>:<fpage>e0186946</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0186946</pub-id><pub-id pub-id-type="pmid">29140982</pub-id><pub-id pub-id-type="pmcid">PMC5687718</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schneider</surname><given-names>H.</given-names></name><name name-style="western"><surname>Griffiss</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Boslego</surname><given-names>J. W.</given-names></name><name name-style="western"><surname>Hitchcock</surname><given-names>P. J.</given-names></name><name name-style="western"><surname>Zahos</surname><given-names>K. M.</given-names></name><name name-style="western"><surname>Apicella</surname><given-names>M. A.</given-names></name></person-group> (<year>1991</year>). <article-title>Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men</article-title>. <source>J. Exp. Med.</source><volume>174</volume>, <fpage>1601</fpage>&#8211;<lpage>1605</lpage>. <pub-id pub-id-type="doi">10.1084/jem.174.6.1601</pub-id><pub-id pub-id-type="pmid">1744587</pub-id><pub-id pub-id-type="pmcid">PMC2119043</pub-id></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schneider</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sahl</surname><given-names>H. G.</given-names></name></person-group> (<year>2010</year>). <article-title>An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway</article-title>. <source>Int. J. Med. Microbiol.</source><volume>300</volume>, <fpage>161</fpage>&#8211;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijmm.2009.10.005</pub-id><pub-id pub-id-type="pmid">20005776</pub-id></mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schutgens</surname><given-names>F.</given-names></name><name name-style="western"><surname>Clevers</surname><given-names>H.</given-names></name></person-group> (<year>2020</year>). <article-title>Human organoids: tools for understanding biology and treating diseases</article-title>. <source>Annu. Rev. Pathol.</source><volume>15</volume>, <fpage>211</fpage>&#8211;<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-pathmechdis-012419-032611</pub-id><pub-id pub-id-type="pmid">31550983</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sender</surname><given-names>R.</given-names></name><name name-style="western"><surname>Fuchs</surname><given-names>S.</given-names></name><name name-style="western"><surname>Milo</surname><given-names>R.</given-names></name></person-group> (<year>2016a</year>). <article-title>Are We really vastly outnumbered? revisiting the ratio of bacterial to host cells in humans</article-title>. <source>Cell</source><volume>164</volume>, <fpage>337</fpage>&#8211;<lpage>340</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.01.013</pub-id><pub-id pub-id-type="pmid">26824647</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sender</surname><given-names>R.</given-names></name><name name-style="western"><surname>Fuchs</surname><given-names>S.</given-names></name><name name-style="western"><surname>Milo</surname><given-names>R.</given-names></name></person-group> (<year>2016b</year>). <article-title>Revised estimates for the number of human and bacteria cells in the body</article-title>. <source>PLoS Biol.</source><volume>14</volume>:<fpage>e1002533</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.1002533</pub-id><pub-id pub-id-type="pmid">27541692</pub-id><pub-id pub-id-type="pmcid">PMC4991899</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>A.</given-names></name><name name-style="western"><surname>Simonson</surname><given-names>T. J.</given-names></name><name name-style="western"><surname>Jondle</surname><given-names>C. N.</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>B. B.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>Mincle-mediated neutrophil extracellular trap formation by regulation of autophagy</article-title>. <source>J. Infect. Dis.</source><volume>215</volume>, <fpage>1040</fpage>&#8211;<lpage>1048</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jix072</pub-id><pub-id pub-id-type="pmid">28186242</pub-id><pub-id pub-id-type="pmcid">PMC5426377</pub-id></mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>A.</given-names></name><name name-style="western"><surname>Steichen</surname><given-names>A. L.</given-names></name><name name-style="western"><surname>Jondle</surname><given-names>C. N.</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>B. B.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Protective role of Mincle in bacterial pneumonia by regulation of neutrophil mediated phagocytosis and extracellular trap formation</article-title>. <source>J. Infect. Dis.</source><volume>209</volume>, <fpage>1837</fpage>&#8211;<lpage>1846</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jit820</pub-id><pub-id pub-id-type="pmid">24353272</pub-id><pub-id pub-id-type="pmcid">PMC4017361</pub-id></mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shiokawa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yamasaki</surname><given-names>S.</given-names></name><name name-style="western"><surname>Saijo</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>C-type lectin receptors in anti-fungal immunity</article-title>. <source>Curr. Opin. Microbiol.</source><volume>40</volume>, <fpage>123</fpage>&#8211;<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1016/j.mib.2017.11.004</pub-id><pub-id pub-id-type="pmid">29169147</pub-id></mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sidorin</surname><given-names>E. V.</given-names></name><name name-style="western"><surname>Solov'eva</surname><given-names>T. F.</given-names></name></person-group> (<year>2011</year>). <article-title>IgG-binding proteins of bacteria</article-title>. <source>Biochemistry</source><volume>76</volume>, <fpage>295</fpage>&#8211;<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1134/S0006297911030023</pub-id><pub-id pub-id-type="pmid">21568864</pub-id></mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silhavy</surname><given-names>T. J.</given-names></name><name name-style="western"><surname>Kahne</surname><given-names>D.</given-names></name><name name-style="western"><surname>Walker</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>The bacterial cell envelope</article-title>. <source>Cold Spring Harb. Perspect. Biol.</source><volume>2</volume>:<fpage>a000414</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a000414</pub-id><pub-id pub-id-type="pmid">20452953</pub-id><pub-id pub-id-type="pmcid">PMC2857177</pub-id></mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soilleux</surname><given-names>E. J.</given-names></name><name name-style="western"><surname>Morris</surname><given-names>L. S.</given-names></name><name name-style="western"><surname>Leslie</surname><given-names>G.</given-names></name><name name-style="western"><surname>Chehimi</surname><given-names>J.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Levroney</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>2002</year>). <article-title>Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro</article-title>. <source>J. Leukoc. Biol.</source><volume>71</volume>, <fpage>445</fpage>&#8211;<lpage>457</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.71.3.445</pub-id><pub-id pub-id-type="pmid">11867682</pub-id></mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sparber</surname><given-names>F.</given-names></name><name name-style="western"><surname>De Gregorio</surname><given-names>C.</given-names></name><name name-style="western"><surname>Steckholzer</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>F. M.</given-names></name><name name-style="western"><surname>Dolowschiak</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ruchti</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>The skin commensal yeast malassezia triggers a type 17 response that coordinates anti-fungal immunity and exacerbates skin inflammation</article-title>. <source>Cell Host Microbe.</source><volume>25</volume>, <fpage>389</fpage>&#8211;<lpage>403.e386</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2019.02.002</pub-id><pub-id pub-id-type="pmid">30870621</pub-id></mixed-citation></ref><ref id="B130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stambach</surname><given-names>N. S.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>M. E.</given-names></name></person-group> (<year>2003</year>). <article-title>Characterization of carbohydrate recognition by langerin, a C-type lectin of langerhans cells</article-title>. <source>Glycobiology</source><volume>13</volume>, <fpage>401</fpage>&#8211;<lpage>410</lpage>. <pub-id pub-id-type="doi">10.1093/glycob/cwg045</pub-id><pub-id pub-id-type="pmid">12626394</pub-id></mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steeghs</surname><given-names>L.</given-names></name><name name-style="western"><surname>van Vliet</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Uronen-Hansson</surname><given-names>H.</given-names></name><name name-style="western"><surname>van Mourik</surname><given-names>A.</given-names></name><name name-style="western"><surname>Engering</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sanchez-Hernandez</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title><italic toggle="yes">Neisseria meningitidis</italic> expressing lgtB lipopolysaccharide targets DC-SIGN and modulates dendritic cell function</article-title>. <source>Cell. Microbiol.</source><volume>8</volume>, <fpage>316</fpage>&#8211;<lpage>325</lpage>. <pub-id pub-id-type="doi">10.1111/j.1462-5822.2005.00623.x</pub-id><pub-id pub-id-type="pmid">16441441</pub-id></mixed-citation></ref><ref id="B132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sung</surname><given-names>S. S.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Rose</surname><given-names>C. E.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Gaskin</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ju</surname><given-names>S. T.</given-names></name><name name-style="western"><surname>Beaty</surname><given-names>S. R.</given-names></name></person-group> (<year>2006</year>). <article-title>A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins</article-title>. <source>J. Immunol.</source><volume>176</volume>, <fpage>2161</fpage>&#8211;<lpage>2172</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.176.4.2161</pub-id><pub-id pub-id-type="pmid">16455972</pub-id></mixed-citation></ref><ref id="B133"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suzuki</surname><given-names>N.</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>K.</given-names></name><name name-style="western"><surname>Toyoshima</surname><given-names>S.</given-names></name><name name-style="western"><surname>Osawa</surname><given-names>T.</given-names></name><name name-style="western"><surname>Irimura</surname><given-names>T.</given-names></name></person-group> (<year>1996</year>). <article-title>Molecular cloning and expression of cDNA encoding human macrophage C-type lectin. Its unique carbohydrate binding specificity for Tn antigen</article-title>. <source>J. Immunol.</source><volume>156</volume>, <fpage>128</fpage>&#8211;<lpage>135</lpage>.<pub-id pub-id-type="pmid">8598452</pub-id></mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takeuchi</surname><given-names>O.</given-names></name><name name-style="western"><surname>Akira</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Pattern recognition receptors and inflammation</article-title>. <source>Cell</source><volume>140</volume>, <fpage>805</fpage>&#8211;<lpage>820</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.01.022</pub-id><pub-id pub-id-type="pmid">20303872</pub-id></mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takeuchi</surname><given-names>O.</given-names></name><name name-style="western"><surname>Hoshino</surname><given-names>K.</given-names></name><name name-style="western"><surname>Akira</surname><given-names>S.</given-names></name></person-group> (<year>2000</year>). <article-title>Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to <italic toggle="yes">Staphylococcus aureus</italic> infection</article-title>. <source>J. Immunol.</source><volume>165</volume>, <fpage>5392</fpage>&#8211;<lpage>5396</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.165.10.5392</pub-id><pub-id pub-id-type="pmid">11067888</pub-id></mixed-citation></ref><ref id="B136"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanaka</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gleinich</surname><given-names>A. S.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Whitfield</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kempe</surname><given-names>K.</given-names></name><name name-style="western"><surname>Haddleton</surname><given-names>D. M.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Specific and differential binding of n-acetylgalactosamine glycopolymers to the human macrophage galactose lectin and asialoglycoprotein receptor</article-title>. <source>Biomacromolecules</source>. <volume>18</volume>, <fpage>1624</fpage>&#8211;<lpage>1633</lpage>. <pub-id pub-id-type="doi">10.1021/acs.biomac.7b00228</pub-id><pub-id pub-id-type="pmid">28418238</pub-id></mixed-citation></ref><ref id="B137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tateno</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ohnishi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Yabe</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hayatsu</surname><given-names>N.</given-names></name><name name-style="western"><surname>Sato</surname><given-names>T.</given-names></name><name name-style="western"><surname>Takeya</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Dual specificity of langerin to sulfated and mannosylated glycans via a single C-type carbohydrate recognition domain</article-title>. <source>J. Biol. Chem.</source><volume>285</volume>, <fpage>6390</fpage>&#8211;<lpage>6400</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.041863</pub-id><pub-id pub-id-type="pmid">20026605</pub-id><pub-id pub-id-type="pmcid">PMC2825434</pub-id></mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>P. R.</given-names></name><name name-style="western"><surname>Reid</surname><given-names>D. M.</given-names></name><name name-style="western"><surname>Heinsbroek</surname><given-names>S. E.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>G. D.</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>S. Y.</given-names></name></person-group> (<year>2005</year>). <article-title>Dectin-2 is predominantly myeloid restricted and exhibits unique activation-dependent expression on maturing inflammatory monocytes elicited <italic toggle="yes">in vivo</italic></article-title>. <source>Eur. J. Immunol.</source><volume>35</volume>, <fpage>2163</fpage>&#8211;<lpage>2174</lpage>. <pub-id pub-id-type="doi">10.1002/eji.200425785</pub-id><pub-id pub-id-type="pmid">15940672</pub-id></mixed-citation></ref><ref id="B139"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Th&#233;paut</surname><given-names>M.</given-names></name><name name-style="western"><surname>Valladeau</surname><given-names>J.</given-names></name><name name-style="western"><surname>Nurisso</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kahn</surname><given-names>R.</given-names></name><name name-style="western"><surname>Arnou</surname><given-names>B.</given-names></name><name name-style="western"><surname>Viv&#232;s</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Structural studies of langerin and Birbeck granule: a macromolecular organization model</article-title>. <source>Biochemistry</source><volume>48</volume>, <fpage>2684</fpage>&#8211;<lpage>2698</lpage>. <pub-id pub-id-type="doi">10.1021/bi802151w</pub-id><pub-id pub-id-type="pmid">19175323</pub-id></mixed-citation></ref><ref id="B140"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thornton</surname><given-names>E. E.</given-names></name><name name-style="western"><surname>Looney</surname><given-names>M. R.</given-names></name><name name-style="western"><surname>Bose</surname><given-names>O.</given-names></name><name name-style="western"><surname>Sen</surname><given-names>D.</given-names></name><name name-style="western"><surname>Sheppard</surname><given-names>D.</given-names></name><name name-style="western"><surname>Locksley</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Spatiotemporally separated antigen uptake by alveolar dendritic cells and airway presentation to T cells in the lung</article-title>. <source>J. Exp. Med.</source><volume>209</volume>, <fpage>1183</fpage>&#8211;<lpage>1199</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20112667</pub-id><pub-id pub-id-type="pmid">22585735</pub-id><pub-id pub-id-type="pmcid">PMC3371730</pub-id></mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tytgat</surname><given-names>H. L.</given-names></name><name name-style="western"><surname>Lebeer</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>The sweet tooth of bacteria: common themes in bacterial glycoconjugates</article-title>. <source>Microbiol. Mol. Biol. Rev.</source><volume>78</volume>, <fpage>372</fpage>&#8211;<lpage>417</lpage>. <pub-id pub-id-type="doi">10.1128/MMBR.00007-14</pub-id><pub-id pub-id-type="pmid">25184559</pub-id><pub-id pub-id-type="pmcid">PMC4187687</pub-id></mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Valladeau</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ravel</surname><given-names>O.</given-names></name><name name-style="western"><surname>Dezutter-Dambuyant</surname><given-names>C.</given-names></name><name name-style="western"><surname>Moore</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kleijmeer</surname><given-names>M.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2000</year>). <article-title>Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules</article-title>. <source>Immunity</source><volume>12</volume>, <fpage>71</fpage>&#8211;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/S1074-7613(00)80160-0</pub-id><pub-id pub-id-type="pmid">10661407</pub-id></mixed-citation></ref><ref id="B143"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Dalen</surname><given-names>R.</given-names></name><name name-style="western"><surname>De La Cruz Diaz</surname><given-names>J. S.</given-names></name><name name-style="western"><surname>Rumpret</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fuchsberger</surname><given-names>F. F.</given-names></name><name name-style="western"><surname>van Teijlingen</surname><given-names>N. H.</given-names></name><name name-style="western"><surname>Hanske</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2019a</year>). <article-title>Langerhans cells sense <italic toggle="yes">staphylococcus aureus</italic> wall teichoic acid through langerin to induce inflammatory responses</article-title>. <source>MBio</source><volume>10</volume>:<fpage>e00330</fpage>&#8211;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1128/mBio.00330-19</pub-id><pub-id pub-id-type="pmid">31088921</pub-id><pub-id pub-id-type="pmcid">PMC6520447</pub-id></mixed-citation></ref><ref id="B144"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Dalen</surname><given-names>R.</given-names></name><name name-style="western"><surname>Fuchsberger</surname><given-names>F. F.</given-names></name><name name-style="western"><surname>Rademacher</surname><given-names>C.</given-names></name><name name-style="western"><surname>van Strijp</surname><given-names>J. A. G.</given-names></name><name name-style="western"><surname>van Sorge</surname><given-names>N. M.</given-names></name></person-group> (<year>2019b</year>). <article-title>A Common Genetic Variation in Langerin (CD207) Compromises cellular uptake of <italic toggle="yes">staphylococcus aureus</italic></article-title>. <source>J. Innate Immun.</source><volume>12</volume>, <fpage>191</fpage>&#8211;<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1159/000500547</pub-id><pub-id pub-id-type="pmid">31141812</pub-id><pub-id pub-id-type="pmcid">PMC7098318</pub-id></mixed-citation></ref><ref id="B145"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van der Aar</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Sylva-Steenland</surname><given-names>R. M.</given-names></name><name name-style="western"><surname>Bos</surname><given-names>J. D.</given-names></name><name name-style="western"><surname>Kapsenberg</surname><given-names>M. L.</given-names></name><name name-style="western"><surname>de Jong</surname><given-names>E. C.</given-names></name><name name-style="western"><surname>Teunissen</surname><given-names>M. B.</given-names></name></person-group> (<year>2007</year>). <article-title>Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition</article-title>. <source>J. Immunol.</source><volume>178</volume>, <fpage>1986</fpage>&#8211;<lpage>1990</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.178.4.1986</pub-id><pub-id pub-id-type="pmid">17277101</pub-id></mixed-citation></ref><ref id="B146"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van der Es</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hogendorf</surname><given-names>W. F.</given-names></name><name name-style="western"><surname>Overkleeft</surname><given-names>H. S.</given-names></name><name name-style="western"><surname>van der Marel</surname><given-names>G. A.</given-names></name><name name-style="western"><surname>Codee</surname><given-names>J. D.</given-names></name></person-group> (<year>2017</year>). <article-title>Teichoic acids: synthesis and applications</article-title>. <source>Chem. Soc. Rev.</source><volume>46</volume>, <fpage>1464</fpage>&#8211;<lpage>1482</lpage>. <pub-id pub-id-type="doi">10.1039/C6CS00270F</pub-id><pub-id pub-id-type="pmid">27990523</pub-id></mixed-citation></ref><ref id="B147"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van der Vlist</surname><given-names>M.</given-names></name><name name-style="western"><surname>de Witte</surname><given-names>L.</given-names></name><name name-style="western"><surname>de Vries</surname><given-names>R. D.</given-names></name><name name-style="western"><surname>Litjens</surname><given-names>M.</given-names></name><name name-style="western"><surname>de Jong</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Fluitsma</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Human langerhans cells capture measles virus through langerin and present viral antigens to CD4(+) T cells but are incapable of cross-presentation</article-title>. <source>Eur. J. Immunol.</source><volume>41</volume>, <fpage>2619</fpage>&#8211;<lpage>2631</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201041305</pub-id><pub-id pub-id-type="pmid">21739428</pub-id></mixed-citation></ref><ref id="B148"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Kooyk</surname><given-names>Y.</given-names></name></person-group> (<year>2008</year>). <article-title>C-type lectins on dendritic cells: key modulators for the induction of immune responses</article-title>. <source>Biochem. Soc. Trans</source>. <volume>36</volume>, <fpage>1478</fpage>&#8211;<lpage>1481</lpage>. <pub-id pub-id-type="doi">10.1042/BST0361478</pub-id><pub-id pub-id-type="pmid">19021579</pub-id></mixed-citation></ref><ref id="B149"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Kooyk</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Geijtenbeek</surname><given-names>T. B.</given-names></name></person-group> (<year>2003</year>). <article-title>DC-SIGN: escape mechanism for pathogens</article-title>. <source>Nat. Rev. Immunol.</source><volume>3</volume>, <fpage>697</fpage>&#8211;<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1038/nri1182</pub-id><pub-id pub-id-type="pmid">12949494</pub-id></mixed-citation></ref><ref id="B150"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Sorge</surname><given-names>N. M.</given-names></name><name name-style="western"><surname>Bleumink</surname><given-names>N. M.</given-names></name><name name-style="western"><surname>van Vliet</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Saeland</surname><given-names>E.</given-names></name><name name-style="western"><surname>van der Pol</surname><given-names>W. L.</given-names></name><name name-style="western"><surname>van Kooyk</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>N-glycosylated proteins and distinct lipooligosaccharide glycoforms of <italic toggle="yes">Campylobacter jejuni</italic> target the human C-type lectin receptor MGL</article-title>. <source>Cell. Microbiol.</source><volume>11</volume>, <fpage>1768</fpage>&#8211;<lpage>1781</lpage>. <pub-id pub-id-type="doi">10.1111/j.1462-5822.2009.01370.x</pub-id><pub-id pub-id-type="pmid">19681908</pub-id></mixed-citation></ref><ref id="B151"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Vliet</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Bay</surname><given-names>S.</given-names></name><name name-style="western"><surname>Vuist</surname><given-names>I. M.</given-names></name><name name-style="western"><surname>Kalay</surname><given-names>H.</given-names></name><name name-style="western"><surname>Garcia-Vallejo</surname><given-names>J. J.</given-names></name><name name-style="western"><surname>Leclerc</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-alpha secretion</article-title>. <source>J. Leukoc. Biol.</source><volume>94</volume>, <fpage>315</fpage>&#8211;<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.1012520</pub-id><pub-id pub-id-type="pmid">23744646</pub-id></mixed-citation></ref><ref id="B152"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Vliet</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Paessens</surname><given-names>L. C.</given-names></name><name name-style="western"><surname>Broks-van den Berg</surname><given-names>V. C.</given-names></name><name name-style="western"><surname>Geijtenbeek</surname><given-names>T. B.</given-names></name><name name-style="western"><surname>van Kooyk</surname><given-names>Y.</given-names></name></person-group> (<year>2008</year>). <article-title>The C-type lectin macrophage galactose-type lectin impedes migration of immature APCs</article-title>. <source>J. Immunol.</source><volume>181</volume>, <fpage>3148</fpage>&#8211;<lpage>3155</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.181.5.3148</pub-id><pub-id pub-id-type="pmid">18713985</pub-id></mixed-citation></ref><ref id="B153"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Vliet</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Steeghs</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bruijns</surname><given-names>S. C.</given-names></name><name name-style="western"><surname>Vaezirad</surname><given-names>M. M.</given-names></name><name name-style="western"><surname>Snijders Blok</surname><given-names>C.</given-names></name><name name-style="western"><surname>Arenas Busto</surname><given-names>J. A.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Variation of <italic toggle="yes">Neisseria gonorrhoeae</italic> lipooligosaccharide directs dendritic cell-induced T helper responses</article-title>. <source>PLoS Pathog.</source><volume>5</volume>:<fpage>e1000625</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1000625</pub-id><pub-id pub-id-type="pmid">19834553</pub-id><pub-id pub-id-type="pmcid">PMC2757725</pub-id></mixed-citation></ref><ref id="B154"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Vliet</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>van Liempt</surname><given-names>E.</given-names></name><name name-style="western"><surname>Saeland</surname><given-names>E.</given-names></name><name name-style="western"><surname>Aarnoudse</surname><given-names>C. A.</given-names></name><name name-style="western"><surname>Appelmelk</surname><given-names>B.</given-names></name><name name-style="western"><surname>Irimura</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells</article-title>. <source>Int. Immunol.</source><volume>17</volume>, <fpage>661</fpage>&#8211;<lpage>669</lpage>. <pub-id pub-id-type="doi">10.1093/intimm/dxh246</pub-id><pub-id pub-id-type="pmid">15802303</pub-id></mixed-citation></ref><ref id="B155"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wamhoff</surname><given-names>E. C.</given-names></name><name name-style="western"><surname>Schulze</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bellmann</surname><given-names>L.</given-names></name><name name-style="western"><surname>Rentzsch</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bachem</surname><given-names>G.</given-names></name><name name-style="western"><surname>Fuchsberger</surname><given-names>F. F.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>A specific, glycomimetic langerin ligand for human langerhans cell targeting</article-title>. <source>ACS Cent Sci.</source><volume>5</volume>, <fpage>808</fpage>&#8211;<lpage>820</lpage>. <pub-id pub-id-type="doi">10.1021/acscentsci.9b00093</pub-id><pub-id pub-id-type="pmid">31139717</pub-id><pub-id pub-id-type="pmcid">PMC6535779</pub-id></mixed-citation></ref><ref id="B156"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Winstel</surname><given-names>V.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sanchez-Carballo</surname><given-names>P.</given-names></name><name name-style="western"><surname>Steglich</surname><given-names>M.</given-names></name><name name-style="western"><surname>Munar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Broker</surname><given-names>B. M.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Wall teichoic acid structure governs horizontal gene transfer between major bacterial pathogens</article-title>. <source>Nat. Commun.</source><volume>4</volume>:<fpage>2345</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms3345</pub-id><pub-id pub-id-type="pmid">23965785</pub-id><pub-id pub-id-type="pmcid">PMC3903184</pub-id></mixed-citation></ref><ref id="B157"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Winstel</surname><given-names>V.</given-names></name><name name-style="western"><surname>Sanchez-Carballo</surname><given-names>P.</given-names></name><name name-style="western"><surname>Holst</surname><given-names>O.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>G.</given-names></name><name name-style="western"><surname>Peschel</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Biosynthesis of the unique wall teichoic acid of <italic toggle="yes">Staphylococcus aureus</italic> lineage ST395</article-title>. <source>MBio</source><volume>5</volume>:<fpage>e00869</fpage>. <pub-id pub-id-type="doi">10.1128/mBio.00869-14</pub-id><pub-id pub-id-type="pmid">24713320</pub-id><pub-id pub-id-type="pmcid">PMC3993852</pub-id></mixed-citation></ref><ref id="B158"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wittmann</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lamprinaki</surname><given-names>D.</given-names></name><name name-style="western"><surname>Bowles</surname><given-names>K. M.</given-names></name><name name-style="western"><surname>Katzenellenbogen</surname><given-names>E.</given-names></name><name name-style="western"><surname>Knirel</surname><given-names>Y. A.</given-names></name><name name-style="western"><surname>Whitfield</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Dectin-2 recognizes mannosylated O-antigens of human opportunistic pathogens and augments lipopolysaccharide activation of myeloid cells</article-title>. <source>J. Biol. Chem.</source><volume>291</volume>, <fpage>17629</fpage>&#8211;<lpage>17638</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M116.741256</pub-id><pub-id pub-id-type="pmid">27358401</pub-id><pub-id pub-id-type="pmcid">PMC5016159</pub-id></mixed-citation></ref><ref id="B159"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>G.</given-names></name><name name-style="western"><surname>Maier</surname><given-names>L.</given-names></name><name name-style="western"><surname>Sanchez-Carballo</surname><given-names>P.</given-names></name><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name><name name-style="western"><surname>Otto</surname><given-names>M.</given-names></name><name name-style="western"><surname>Holst</surname><given-names>O.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Glycosylation of wall teichoic acid in <italic toggle="yes">Staphylococcus aureus</italic> by TarM</article-title>. <source>J. Biol. Chem.</source><volume>285</volume>, <fpage>13405</fpage>&#8211;<lpage>13415</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.096172</pub-id><pub-id pub-id-type="pmid">20185825</pub-id><pub-id pub-id-type="pmcid">PMC2859500</pub-id></mixed-citation></ref><ref id="B160"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamasaki</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ishikawa</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sakuma</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hara</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ogata</surname><given-names>K.</given-names></name><name name-style="western"><surname>Saito</surname><given-names>T.</given-names></name></person-group> (<year>2008</year>). <article-title>Mincle is an ITAM-coupled activating receptor that senses damaged cells</article-title>. <source>Nat. Immunol.</source><volume>9</volume>, <fpage>1179</fpage>&#8211;<lpage>1188</lpage>. <pub-id pub-id-type="doi">10.1038/ni.1651</pub-id><pub-id pub-id-type="pmid">18776906</pub-id></mixed-citation></ref><ref id="B161"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kamiya</surname><given-names>T.</given-names></name><name name-style="western"><surname>Suabjakyong</surname><given-names>P.</given-names></name><name name-style="western"><surname>Tsuji</surname><given-names>N. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Targeting C-type lectin receptors for cancer immunity</article-title>. <source>Front. Immunol.</source><volume>6</volume>:<fpage>408</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2015.00408</pub-id><pub-id pub-id-type="pmid">26379663</pub-id><pub-id pub-id-type="pmcid">PMC4547497</pub-id></mixed-citation></ref><ref id="B162"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yanagimachi</surname><given-names>M. D.</given-names></name><name name-style="western"><surname>Niwa</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>T.</given-names></name><name name-style="western"><surname>Honda-Ozaki</surname><given-names>F.</given-names></name><name name-style="western"><surname>Nishimoto</surname><given-names>S.</given-names></name><name name-style="western"><surname>Murata</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Robust and highly-efficient differentiation of functional monocytic cells from human pluripotent stem cells under serum- and feeder cell-free conditions</article-title>. <source>PLoS ONE</source><volume>8</volume>:<fpage>e59243</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0059243</pub-id><pub-id pub-id-type="pmid">23573196</pub-id><pub-id pub-id-type="pmcid">PMC3616072</pub-id></mixed-citation></ref><ref id="B163"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>K.</given-names></name><name name-style="western"><surname>He</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Park</surname><given-names>C. G.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>Y. S.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Han</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title><italic toggle="yes">Yersinia pestis</italic> interacts with SIGNR1 (CD209b) for promoting host dissemination and infection</article-title>. <source>Front. Immunol.</source><volume>10</volume>:<fpage>96</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.00096</pub-id><pub-id pub-id-type="pmid">30915064</pub-id><pub-id pub-id-type="pmcid">PMC6422942</pub-id></mixed-citation></ref><ref id="B164"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>K.</given-names></name><name name-style="western"><surname>Park</surname><given-names>C. G.</given-names></name><name name-style="western"><surname>Cheong</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bulgheresi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Host Langerin (CD207) is a receptor for <italic toggle="yes">Yersinia pestis</italic> phagocytosis and promotes dissemination</article-title>. <source>Immunol. Cell Biol.</source><volume>93</volume>, <fpage>815</fpage>&#8211;<lpage>824</lpage>. <pub-id pub-id-type="doi">10.1038/icb.2015.46</pub-id><pub-id pub-id-type="pmid">25829141</pub-id><pub-id pub-id-type="pmcid">PMC4612776</pub-id></mixed-citation></ref><ref id="B165"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshida</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kubo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fujita</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yokouchi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ishii</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kawasaki</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Distinct behavior of human langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis</article-title>. <source>J. Allergy Clin. Immunol.</source><volume>134</volume>, <fpage>856</fpage>&#8211;<lpage>864</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2014.08.001</pub-id><pub-id pub-id-type="pmid">25282566</pub-id></mixed-citation></ref><ref id="B166"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>Q. D.</given-names></name><name name-style="western"><surname>Oldring</surname><given-names>A. P.</given-names></name><name name-style="western"><surname>Powlesland</surname><given-names>A. S.</given-names></name><name name-style="western"><surname>Tso</surname><given-names>C. K.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Drickamer</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Autonomous tetramerization domains in the glycan-binding receptors DC-SIGN and DC-SIGNR</article-title>. <source>J. Mol. Biol.</source><volume>387</volume>, <fpage>1075</fpage>&#8211;<lpage>1080</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2009.02.046</pub-id><pub-id pub-id-type="pmid">19249311</pub-id><pub-id pub-id-type="pmcid">PMC2680971</pub-id></mixed-citation></ref><ref id="B167"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>G. L.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>X. S.</given-names></name></person-group> (<year>2018</year>). <article-title>Synthetic glycans and glycomimetics: a promising alternative to natural polysaccharides</article-title>. <source>Chemistry</source><volume>24</volume>, <fpage>6696</fpage>&#8211;<lpage>6704</lpage>. <pub-id pub-id-type="doi">10.1002/chem.201705469</pub-id><pub-id pub-id-type="pmid">29282776</pub-id></mixed-citation></ref><ref id="B168"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>O.</given-names></name><name name-style="western"><surname>Pantelic</surname><given-names>M.</given-names></name><name name-style="western"><surname>Li</surname><given-names>G.</given-names></name><name name-style="western"><surname>Knazze</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Nobile</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2006a</year>). <article-title>DC-SIGN (CD209) recognition of <italic toggle="yes">Neisseria gonorrhoeae</italic> is circumvented by lipooligosaccharide variation</article-title>. <source>J. Leukoc. Biol.</source><volume>79</volume>, <fpage>731</fpage>&#8211;<lpage>738</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.0405184</pub-id><pub-id pub-id-type="pmid">16461738</pub-id></mixed-citation></ref><ref id="B169"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Skurnik</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S. S.</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>O.</given-names></name><name name-style="western"><surname>Kalyanasundaram</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bulgheresi</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Human dendritic cell-specific intercellular adhesion molecule-grabbing nonintegrin (CD209) is a receptor for <italic toggle="yes">Yersinia pestis</italic> that promotes phagocytosis by dendritic cells</article-title>. <source>Infect. Immun.</source><volume>76</volume>, <fpage>2070</fpage>&#8211;<lpage>2079</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.01246-07</pub-id><pub-id pub-id-type="pmid">18285492</pub-id><pub-id pub-id-type="pmcid">PMC2346686</pub-id></mixed-citation></ref><ref id="B170"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Snyder</surname><given-names>S.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>P.</given-names></name><name name-style="western"><surname>Azadi</surname><given-names>P.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bulgheresi</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2006b</year>). <article-title>Role of N-acetylglucosamine within core lipopolysaccharide of several species of gram-negative bacteria in targeting the DC-SIGN (CD209)</article-title>. <source>J. Immunol.</source><volume>177</volume>, <fpage>4002</fpage>&#8211;<lpage>4011</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.177.6.4002</pub-id><pub-id pub-id-type="pmid">16951363</pub-id></mixed-citation></ref><ref id="B171"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Diaz-Arevalo</surname><given-names>D.</given-names></name><name name-style="western"><surname>Guan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Noninvasive vaccination against infectious diseases</article-title>. <source>Hum. Vaccin. Immunother.</source><volume>14</volume>, <fpage>1717</fpage>&#8211;<lpage>1733</lpage>. <pub-id pub-id-type="doi">10.1080/21645515.2018.1461296</pub-id><pub-id pub-id-type="pmid">29624470</pub-id><pub-id pub-id-type="pmcid">PMC6067898</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>